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ABSTRACT
The widespread use of pesticides by farmers, pest control operators and
even the general public can pose significant risks to children's health. One
particular pesticide, chlorpyrifos, was the most widely used pesticide in the
United States with total use estimated at approximately 30 million pounds per
year. Young children and the developing fetus are far more susceptible to the
effects of pesticide exposure as a result of unusual exposure patterns and
developmental immaturities. Transplacental transfer and lactational exposure are
the pathways exclusive to the developing fetus and infant. Chlorpyrifos exposure
is of special concern in this population because of its potential for disruption of
normal brain function and cognitive development.
The purpose of this study was to determine the concentration of
chlorpyrifos in three different biological specimens: breast milk, plasma, and
saliva. The research method employed for this study was a secondary analysis of
existing samples collected for the purposes of a prior study. Based on specimen
availability, there were a total of 26 subjects each for the lactating group and the
non-lactating group. The lactation group had 26 matched breast milk, plasma and
saliva samples and the non-lactation group had 26 matched plasma and saliva
samples. The biological specimens were tested in the laboratory using an assay
specific to chlorpyrifos. The Chlorpyrifos RaPID Assay was developed by
Strategic Diagnostics, Inc and had a detection limit of 0.1 ng/ml (ppb) and a
linear range of 0.22 to 3.0 ng/ml (ppb).

v

Overall, for the lactation group, 25/26 samples were positive for
chlorpyrifos with milk concentrations significantly higher than plasma or salivary
concentrations. 19126 plasma samples were positive and 10/26 saliva samples
were positive for chlorpyrifos. For the non-lactation group, 23/26 plasma samples
were positive for chlorpyrifos and 16/26 saliva samples were positive. In addition,
the plasma chlorpyrifos concentrations were significantly higher than salivary
concentrations in the non-lactation group. Comparing the two groups, salivary
chlorpyrifos concentrations were significantly higher in the lactation group.
There is mounting evidence of pesticide contamination in the breast milk
of lactating women. This study has contributed to this knowledge by documenting
chlorpyrifos concentrations in breast milk, plasma, and saliva of lactating and
non-lactating mothers. However, further research needs to be done to determine
what these chemicals are doing to our children.
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CHAPTER ONE
INTRODUCTION
The widespread use of pesticides by farmers, pest control operators and
even the general public can pose significant risks to human health, especially
children. One particular pesticide, chlorpyrifos, is the most widely used pesticide
in the United States with total use estimated at approximately 30 million pounds
per year (EWG, 1998). Young children and the developing fetus are far more
susceptible to the effects of pesticide exposure as a result of unusual exposure
patterns and developmental immaturities. Transplacental transfer and lactational
exposure are the pathways exclusive to the developing fetus and infant
(Byczkowski, Kacew, Miller, Pelkoneu & Saunders, 2001). Because brain growth
is very rapid prior to and following birth, chlorpyrifos exposure is of special
concern in this population because of its potential for disruption of normal brain
growth function and cognitive development. There is mounting concern that
repeated low-level exposure to organophosphorus pesticides in utero or
postnatally increases the risk of poor performance on neurobehavioral and
cognitive examinations during infancy and childhood (Olson, Blank, & Menton,
1998; Weiss & Landrigan, 2000).

Pesticides
Pesticides, which include insecticides, herbicides, and fungicides, are
regulated under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).
This was the first attempt to address the potential risks to human health posed by
pesticide products. The act directs the Environmental Protection Agency (EPA) to
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restrict the use of pesticides as necessary to prevent unreasonable adverse
effects on people and the environment and prohibits the sale of any pesticide in
the US unless it is registered and labeled according to appropriate uses and
restrictions. This law specifies that a pesticide may not be marketed until the EPA
has registered it. To register a pesticide as an active ingredient, pesticide
product, or a new use of a registered pesticide, The EPA requires submission of
scientific data on pesticide toxicity and behavior in the environment (this may
require data from any combination of more than 100 different tests, depending on
the toxicity and degree of exposure).
Toxicity studies are required to assess the potential hazards to humans
through varying degrees of exposure (acute, sub-chronic, and chronic) of lab
animals to pesticides. Acute toxicity studies provide information on short-term
exposures. The first step evaluates oral, dermal, and inhalation toxicities. Sub
chronic (90 day) studies provide information on toxicities that may be a result of
repeated exposures to a pestiCide over a period up to 30% of the lifetime of a
rodent. Chronic (1 to 2 year) studies provide information on toxicities that occur
over a large portion of the life span with particular emphasis on carcinogenicity or
tumor development. Unfortunately, the EPA does not routinely require
neurodevelopmental toxicity testing or functional assessment of the nervous
system, even on neurotoxic chemicals (Wallinga, 1998). Nor do they require
lifetime testing of those animals exposed in utero or infancy to assess for
diseases that might develop later in life. A pesticide is subjected to close scrutiny
if the EPA concludes that the chemical poses a significant risk to humans based
2

on animal studies. However, even if a pesticide is convincingly shown to be
teratogenic, the law allows the chemical to be registered if the economic benefits
outweigh the risk (Chaffrey, 2000).
Due to the increasing environmental concerns and the vulnerabilities of
developing infants and children, Congress specifically requested that the EPA
increase the stringency of its requirements for neurotoxic and behavioral testing
on prenatal and neonatal animals (Merrill, 2001). Of the 800,000 pesticides on
the market, only a few have been evaluated for their cumulative effects on
children, and most of the 140 neurotoxic pesticides have not been tested
(Anderson, Nielsen, & Grandjean, 2000). The EPA advisory committee has
recently identified organophosphate insecticide effects as one of the five areas
where children's vulnerabilities have not been adequately assessed by existing
EPA regulations (Wigle, 2003).
Because humans are exposed to a variety of chemicals in the
environment, US Supreme Court validated the need for a method to determine
the inherent health risks associated with chemical exposure. Together with
Federal Regulatory Agencies, a framework was developed. This was known as
Risk Assessment in the Federal Government: Managing the Process (or simply
the Red Book). Risk assessment is defined as the systematic scientific
characterization of potential adverse health effects resulting from human
exposure to hazardous agents (Hooper, 1989). Because all chemical risk
assessment scenarios are not the same, the risk assessment process provides a
methodological approach to ensure consistent analYSis of different chemicals.
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This process involves four steps: hazard identification, dose-response
assessment, exposure assessment, and risk characterization or effects
assessment (Faustman & Omenn, 2001).
Hazard identification involves the toxicity assessment of chemicals and
whether they have the ability to produce adverse health effects in animals or
humans. This can involve structure-activity analysis, animal bioassays, and
epidemiological approaches. Structure activity relationships (SARS) predict toxic
properties from information on molecular structure with the concept that if a
particular chemical is known to be a carcinogen then another chemical with the
same molecular structure will also be a carcinogen (Gramatica, 2004). Lifetime
animal assays were developed as a gold standard to establish such end points
as carcinogenicity or teratogenicity. The premise with this test was that it would
be extrapolated to humans. The most convincing hazard assessment approach
involves the use of epidemiological studies to assess the correlation between
exposure and disease.
The second step of the risk assessment process is that of the chemical
toxicity or dose-response assessment. This step is important in determining
where on the dose-response curve an adverse health effect is expected to occur
or. Sometimes it is used to determine the safe exposure level that is sufficiently
small enough not to cause any adverse human health effects. The threshold
dose is the dose below, which no change in biological response occurs, followed
by the no observed adverse effect level (NOAEL) and the lowest observed
adverse effect level (LOAEL).
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The exposure assessment involves a quantitative estimation of the
environmental exposure and the subsequent entry into the human body. This
assessment addresses three areas: the exposure (the number of people
exposed at specific concentrations for the time period of interest), the resulting
dose, and the cause (the contribution of important sources and pathways to
exposure or dose) (Sexton et ai, 1995). The primary goal is not only to determine
the amount of exposure but also to find out how much of a specific agent may be
reaching target organs in the body.
Risk characterization is the final step in the risk assessment and is also
know as the effects assessment. This step utilizes all of the information obtained
in the previous three previous quantitative methods to provide a qualitative
conclusion of the likelihood that a particular chemical is able to produce adverse
health effects and is therefore, a human health hazard (Sexton et ai, 1995).
Other questions addressed in risk characterization include: what is the nature
and estimated incidence of adverse effects in a given population and how robust
is the evidence?
Because there are so many inherent assumptions and extrapolations
being made, the risk assessment process can be a source of uncertainty versus
actuality. Although some believe that the predominant problem with the risk
assessment is over exaggeration or risk estimates, the majority of scientists,
toxicologists, and regulatory agencies believe that there are flaws in the process
that need to be improved. The extrapolation process is considered a weakness
because of the uncertainty associated with the assessment factors.

5
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Extrapolations may be from one species to another or within the same species,
from one route of exposure in one species to a different route of exposure in
another species, and from continuous exposure conditions in the laboratory to
varying human exposures in the environment. Although the debate over the risk
assessment is well founded due to the potential inadequacies and uncertainties,
the process does provide valuable environmental toxicological information on
potential human health hazards.

Insecticides. Insecticides are classified according to three major
categories, the organochlorides, the pyrethroids, and the anticholinesterase
agents. The differences between the effects of these various chemicals relate
primarily to their ability to interfere with the membrane transport of sodium,
potassium, calcium, or chloride; ability to inhibit enzyme activities; or the ability to
inhibit the breakdown of neurotransmitters at nerve endings (Ecobichon, 2001).
The United States government banned several chemicals in the organochloride
class because of their high toxicity potential. The year 1962 was known as the
"Silent Spring" because of one such chemical. DDT, one of the most powerful
pesticides the world has ever known, was developed in 1939 to protect U.S.
troops from malaria in the South Pacific Islands. The inventor was awarded the
Nobel Prize. It became available for civilian use in 1945. Thirteen years later, a
marine biologist with the U.S. Fish and Wildlife Service received a letter from a
friend outlining the dangers associated with DDT sprayings. It took four years for
Rachel Carson to complete the book entitled "Silent Spring". The book
meticulously described the sequential effects associated with DDT sprayings.
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Following a single crop application of DDT, it remained toxic in the environment
for years even after it was diluted by rainwater. Not only was DDT killing insects
but also fish, birds and eventually up the food chain to humans and thereby
contaminating the entire world food supply. The book's final chapter illustrates a
nameless American town where all life, from fish to birds to apples to human
children, had been silenced by the insidious effects of DDT (Carson, 1962). As a
result, the EPA banned the use of DDT in 1972. In the late 1980's the EPA also
banned other highly toxic organochlorine chemicals like Aldrin, Dieldrin, and
Chlordane.
The anticholinesterase insecticides include two chemical classes, the
carbamates and the organophosphates. These particular chemicals have
become widely used as replacements for the more persistent organochlorides
but are receiving more attention because of their acute neurobehavioral effects.
Carbamates are primarily used in vector control on lawns and gardens. They are
part of a large group of synthetic pesticides that have been developed in the last
40 years.
The organophosphates were first developed for agricultural use for the
control of insects. Their acute lethality is due to their ability to inhibit an enzyme
that is vital to normal nerve function. Subsequently, organophosphates have
been used on humans as well. The Germans used them in WWII as chemical
warfare agents (Ecobichon, 1997). Japanese terrorists used them as nerve
agents in a Tokyo subway in 1995, and there have been concerns of possible
organophosphate use in the first Gulf War.
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The organophosphates are esters of phosphoric or phosphorothioic acids
with R1. R2, and R3 substituents directly to or through an oxygen to the
phosphorus carbon. These substituents can include the alkyl, alkoxy, or aryl
groups (Chambers, 1992). Metabolism occurs chiefly by hydrolysis in the liver.
Since the breakdown is relatively slow, significant storage in body fat may occur.
Some organophosphates are extremely lipid soluble allowing them to be stored
in fat with subsequent delayed toxicity due to late release (Ecobichon, 2001).
There are direct and indirect organophosphate inhibitors. Those that are
direct (parathion, diazinon, malathion, and chlorpyrifos) require metabolic
activation before they can inhibit acetylcholinesterase. This activation is
accomplished by the conversion from a thion (P=S) to an oxon (P=O) by the
action of the liver microsomes utilizing the cytochrome P450 enzymes (Vale,
1998). Oxidative desulfuration results in the formation of the oxon of the parent
compound. Ultimately, both thions and oxons are hydrolyzed at the ester linkage,
yielding alkyl phosphates and leaving groups, which are then either excreted or
further transformed in the body (Ecobichon, 1997).
Chlorpyrifos. This very common organophosphate gained popularity in
1965 because of the decreased availability of chemicals in the organochlorine
class. In the mid 1990's, chlorpyrifos was ranked 12th in frequency of indoor
pesticide applications and 5th in frequency of outdoor pesticide applications
(Robinson, Pease & Albright, 1994). According to the NHEXAS study by Sexton
et al (1995) and the Minnesota Children's Pesticide study by Quackenboss et al
(2000), the majority of the U.S. population is exposed to chlorpyrifos. These
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epidemiological studies reported measurable concentrations of TCP (3, 5, 6
trichlor0-2-pyridinol), the primary urinary metabolite of chlorpyrifos, in 82°k of 993
adults and 92% of children. Chlorpyrifos residues were also found in air samples
in 83-97°k of homes in Florida and in 30-40% of homes in Massachusetts
(Whitmore, Immerman, Camann, Bond, Lewis & Schaum, 1994). There are
approximately 822 registered products containing chlorpyrifos on the market that
are applied in and around homes more than 20 million times a year in the United
States (Steenland, Dick, Howell, Chrislip, Hines, & Reed, 2000). Manufacturers
of chlorpyrifos earn a reported $350 million a year from chlorpyrifos sales in the
United States, not including exports sales to over 88 countries.
Agriculturally, chlorpyrifos is used on a variety of food crops such as citrus
crops, vegetable crops, and tree fruits. It is also used as a mosquitocide and as
an insecticidal ear tag for cattle. Professionally, chlorpyrifos is used in residential
and commercial buildings, schools, daycare centers, hotels, restaurants,
hospitals, and food manufacturing plants. The majority of urban use is involved in
termite control around baseboards. It is also injected into cracks and crevices for
roach control and as a broadcast application in the treatment of fleas.
The most common use of this pesticide occurs in the home by the so
called "do-it-yourselfers" as it can be found under the sinks or in the garages of
most homes. Chlorpyrifos-containing products are used in the kitchen, bathroom,
and other living spaces (Whitmore, Kelly, & Reading, 1992). It is used as a spray
to kill roaches or ants, and it is used as a fogger to get rid of fleas. Such products
include: Black Flag Roach and Ant Killer, Ortho Home Pest Insect Control and
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Lawn Insect Spray, Raid Ant Controller and Home Insect Killer Formula,
Sergeant's Fast-Acting Flea and Tick Collar, and Hartz 30 Day Flea and Tick
Collar for Dogs. Indoor use by unlicensed or untrained applicators has resulted in
excessive human exposure with most of the incidents occurring as a result of
misuse (Blondell, Suhre & Smegal, 1999). Among the general population, people
who use the insecticide in homes and gardens and people who ingest food
exposed to chlorpyrifos are at higher risks of exposure (U.S. Department of
Health and Human Services, 1997).
Chlorpyrifos, [0, O-diethyl 0- (3, 5, 6-trichloro-2-pyridinyl)
phosphorothionate] is a broad-spectrum organophosphate insecticide. It acts
primarily as a contact poison and is available in a variety of formulations
(granules, powder, and liquid spray). Chlorpyrifos enters the environment as a
result of its widespread use as an insecticide. It is released into the air by
volatilization during foliage or soil application or by broadcast application.
Chlorpyrifos is considered a moderately volatile chemical meaning that it will
exist primarily in the vapor phase but will also partition to available airborne
particulate suggesting that it may travel long distances in the air (Racke, 1993).
Chlorpyrifos is considered to be practically insoluble in water, but
persistence in water has been measured between 35 and 140 days (McDougall,
Wan & Harris, 1994). It has a strong tendency to partition into the soil and
sediment and has an affinity for sorption. Once in the soil, chlorpyrifos degrades
under ultraviolet light via chemical hydrolysis and by the action of soil microbes.
The persistence of chlorpyrifos in soil metabolism half-life ranges from 11 to 180
10

days; however, much longer soil half-lives of 175 to 1576 days has been reported
following termiticide applications (Howard, 1991). Once in the environment,
chlorpyrifos can then accumulate into living creatures resulting in
bioaccumulation up the food chain. Chlorpyrifos has been found to be extremely
toxic to freshwater fish (Srivasta, Tiwari & Srivastava, 1990), birds (Simpson,
1984), cats (Jaggy & Oliver, 1990), and monkeys (Brack & Rothe, 1982).

Exposure Assessment
Chlorpyrifos exposure can occur through several pathways. Oral exposure
occurs through the ingestion of residues on food crops, fish, meat, or dairy
products. The U.S. Food and Drug Administration (1994) found that chlorpryifos
was the fifth most common detected pesticide on food crops. Chlorpyrifos
residues have been found in channel catfish following waterborne exposure
(Barron, Plakas & Wilga, 1991). Residues have also been found in beef (Ivey,
Mann & Oehler, 1972) and pork (Ivey & Palmer, 1979) following treatment for
ticks and lice. In all cases fat appeared to have higher chlorpyrifos concentrations
than other tissues (Cox, 1995). Residues were also found in dairy cow milk and
cream (McKellar, 1976).
Dermal exposure can occur through skin contact with contaminated
surfaces. Chlorpyrifos residues were detectable on soft, absorbent surfaces,
such as stuffed toys, furniture, and carpet for up to two weeks following a fogging
application (Gurnunathan, Freeman, Buckley, Roy, Meyer, Bukowski & Lioy,
1998). Transferable chlorpyrifos residues have been found on children following
direct contact with their treated pets (Boone, Tyler & Chambers, 2001).
11
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Inhalation exposure can occur from the aerosols and vapors associated
with spraying or fogging techniques. Crack and crevice treatments are applied
where the insect is most likely to be found. Chlorpyrifos residues have been
found in air samples for up to eight years following termite application (Wright,
Leidy & Dupree, 1994). Broadcast applications have found chlorpyrifos residues
up to 10 days following treatment (Currie, McDonald & Chung, 1990). Air
residues were also collected for up to 30 days following the use of chlorpyrifos
pest control strips (Jackson & Lewis, 1981).
Because chlorpyrifos is extremely lipid soluble and therefore poorly
eliminated, there is great concern that this chemical can be transferred from the
pregnant woman to the developing fetus. In the developing fetus, the exclusive
exposure pathway is transplacental transfer from the mother's blood circulation to
the placenta. Because the placenta is a lipid membrane, lipid soluble chemicals
that are nonionized with low molecular weights rapidly cross the placenta to the
fetus. Evidence of anticholinesterase insecticide transfer (eg. organophosphates
and carbamates) has been substantiated in the literature by measurements of
cholinesterase inhibition in fetal tissues (Gupta & Sastry, 1995; Lassiter, Barone,
Moser & Padilla, 1999). Whyatt and Barr (2001) also provided evidence of
organophosphate placental transfer in their study of newborn meconium.
Chlorpyrifos metabolites were found in 95-100% of meconium samples collected
from the diapers of 20 newborns.
Lactational transfer pathway. The lactational transfer pathway is another

possible route of infant exposure to chlorpyrifos. Lipophilic chemicals can
12

accumulate in maternal fat reserves and then be mobilized through lactation and
transferred to the nursing infant through the process of depuration (Groer,
Humenick & Wilson, 2002). In this process, lipophilic compounds can be
released from storage depots or fat deposits and then released back into
circulation, allowing them to be taken up into the fat of the mammory gland
(Clewell & Gearhart, 2002). There are approximately 50 environmental
contaminants that have been detected in human milk (Giroux, Lapointe & Baril,
1992). Since breast tissue has a high fat content, it is possible that chlorpyrifos
is transferred to the infant during lactation, thus becoming an excretion pathway
for the mother. The transfer of chemicals from maternal blood to breast milk is
dependent upon the following factors: the chemical, the mother, the milk, and the
infant.
The factors associated with chemical transfer include: 1) lipid solubility, 2)
molecular weight, 3) protein binding, and 4) degree of pH ionization (Pons, Rey &
Matheson, 1994). Lipid soluble chemicals partition into cell membranes more
rapidly than water soluble chemicals in that they rapidly dissolve into the lipid
bilayer. This process is known as the lipid (or octanol): water partition coefficient.
Unlike plasma, breast milk contains emulsified fat (approximately 3.2 to 3.6%)
that can concentrate lipid soluble molecules (8yczkowski et ai, 2001).
The mammary epithelium membrane is semipermeable in that it allows
chemicals of low molecular weights passage through the membrane. Generally,
chemicals that have a molecular weight of 200 or greater have difficulty crossing
the lipid membrane but studies have shown that large molecules can cross over
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into breast milk (Black, 1996). Larger chemical molecules may be transported
biologically active into the alveolar cell by pinocytosis (engulfing of liquids or
particles) and then released into the milk by apocrine secretion (Institute of
Medicine, 1991).
Chemicals are transported in the bloodstream unbound or partly bound to
blood components (plasma or proteins). Only those chemicals that are not
protein bound can leave the maternal circulation and diffuse across the cell
membrane. By binding to proteins, chemical molecules become trapped and
unavailable for lactational transfer. Breast milk contains several proteins;
however, none of the major proteins tend to bind chemicals (Clewell and
Gearhart, 2002). The lipid soluble chemicals are most often stored in adipose
tissues and are in exchange with the circulatory system to reach equilibrium. This
results in the toxicant being mobilized into the blood for further distribution and
elimination or being redeposited in other adipose tissue.
The degree of ionization is the final factor associated with the chemicals
transferability into breast milk. Most chemicals are either weak acids or weak
bases and exist in either an ionized or non-ionized form (Harvey & Champe,
1992). Weak bases are nonionized in plasma which increases their lipid solubility
and transferability into breast milk. This degree of ionization determines the
percentage of un-ionized molecules that can cross the membrane (Wilson,
1981). Distribution of an ionized molecule is determined by its pKa (the pH at
which concentrations of non-ionized and ionized forms of the chemical are
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equal). For a weak acid, the higher the pH, the lower the ratio of unionized to
ionized forms. The opposite is true for a weak base. The lower pH of milk (6.8
compared to plasma at 7.4) allows some weak bases to become ionized
preventing them from diffusing back across the membrane (Byczkowski, 2001).
The chemical then becomes trapped with the possibility of achieving an even
higher concentration in the milk. Therefore those chemicals that are lipid soluble
with weak bases generally pass through the membrane easily, concentrate in the
milk fat globules that then lead to a high ratio of the chemical in milk as
compared to the plasma (Dorman et ai, 2001)
Several maternal factors influence the risk of chemical concentration in the
breast milk. These factors include the route of exposure, the amount of chemical
absorbed into maternal circulation, maternal age and weight, number of births,
and timing and duration of lactation (Barrett, 2001). The route of exposure will
determine how much of the chemical will be absorbed and distributed to the
target sites. Because most toxicants are accumulated over the lifespan,
bioaccumulation would be expected to increase with age. Maternal weight or
body fat contributes to the concentration of chemicals in the breast milk as
persistent lipophilic toxicants are stored in fat deposits. First-born children who
were breast-fed would be exposed to a higher concentration of toxicants than
subsequent children (Furst, Kruger, Meemke & Groebel, 1989). Since the lipid
content in breast milk varies according to feedings, those who nursed for longer
periods at a time would be exposed to a higher concentration than those that
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nurse for short periods of time (Clewell & Gearhart, 2002). Lactation may be an
efficient way to excrete the maternal body burden of such toxicants in that some
species can reduce their body burden by as much as 60-80% (Byczkowski,

2001).
Lactational factors include milk composition, milk to plasma ratio, and
blood milk barrier. The composition of milk changes according to the gestational
age of the baby. Lactogenesis occurs around the time of delivery and is defined
as the onset of copious milk secretion (Neville, Morton & Umemura, 2001).
During stage 1 alveolar cells are differentiated from secretory cells. In stage 2
(occurs day 2 or 3 to day 8 following birth) endocrine control switches to
autocrine (supply-demand) control and milk secretion begins (Neville et ai, 2001).
The first milk that is secreted is known as colostrum and contains large quantities
of protective substances needed for the newborn. It is full of proteins, vitamins,
and immunoglobulins. The next milk stage is commonly called transition milk as it
occurs days 6-10. During this stage, immunoglobulin and protein content falls
while fat and sugar contents rise (10M, 1991). Fat content during lactogenesis
increases from 2.9% in the first week to approximately 4% in mature milk. In
addition, the fat content in hindmilk is higher than foremilk, 4-6% and 1-2%,
respectively. (Needham & Wang, 2002).
Galactopoiesis (later than 9 days after birth) is referred to as the mature
milk stage. Milk volume increases from a mean of 50 ml per day to approximately

500 ml per day. The milk that comes at the beginning of the feeding is known as
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the foremilk and has a high level of sugar, protein, vitamins and minerals and a
lower level of fat. The hindmilk comes towards the end of the feeding and is
much richer in fat. This diurinal variation is more likely due to the varying degrees
of breast emptying as opposed to a variation in lipid synthesis (10M, 1991).
The milk to plasma (M/P) ratio refers to the amount of chemical milk
concentration compared to maternal plasma (Ito & Koren, 1994). The amount of
chemical concentration in milk depends on its half-life in the plasma and the rate
of transfer across the mammary epithelium membrane. Those chemicals with a
short plasma half-life may not have time to equilibrate across the epithelium
resulting in higher plasma concentrations and lower milk concentrations. The milk
to plasma ratio is used to determine the extent of chemical excretion in the milk.
Those chemicals with a low M/P ratio are less likely to cause adverse effects in
the nursing infant; however, most environmental chemicals have higher ratios
which is due to their lipophilicity, poor water solubility and small ionization
potential (Berlin & Kacew, 1997).
The infant factors associated with the risk of chemical toxicity include the
frequency and volume of feedings, absorption and distribution of the chemical,
and clearance of the chemical by the infant. Those infants that breastfeed eight
times or more a day are more likely to have a higher chemical concentration than
those that breast-feed only once or twice a day. For infants one to six months
old, the EPA (1997) suggests using an average breast milk intake of 742 mllday.
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Once inside the body, the chemical is distributed to target organs or
storage depots via the bloodstream. Since adipose and breast milk are
considered lipid rich matrices, lipophilic chemicals tend to partition among the
lipid stores in blood, breast milk, and adipose tissue on a 1:1: 1 basis (Clewell &
Gearhart, 2002). Chemicals can also be deposited in secretory structures such
as tears, saliva, sweat, and milk (Barr, Wang, & Needham, 2005).

Effects Assessment
Toxicokinetics is the study of how a substance gets into the body and
what happens to it once in the body. The processes involved include absorption,
distribution, biotransformation, and excretion. Toxicants that are absorbed
through the gastrointestinal tract are carried by the blood directly to the liver and
are subject to biotransformation or excretion by the liver. Those that are
absorbed through the lung or skin enter the bloodstream with blood filtered by the
liver and kidneys. Once chlorpyrifos is absorbed into the bloodstream it may be
excreted, stored, biotransformed into a different chemical or metabolite, its
metabolites may be excreted or stored, and/or it or its metabolites may interact or
bind with cellular components (Ecobichon, 2001). If a chemical is biotransformed
into hydrophilic metabolites then it becomes detoxified, or less toxic, and is more
easily excreted by the kidneys. However, sometimes it can be biotransformed
into metabolites that are more toxic than the parent compound, which is known
as bioactivation (Ecobichon, 2001).
The liver is the primary biotransforming organ due to its high concentration
of enzymes. The primary enzyme system is the cytochrome P450 enzymes, a
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microsomal superfamily of isoenzymes that transfer electrons and thereby
catalyze the oxidation of many chemicals (Wexler, 1998). Phase 1 reactions
involve the formation of a new or modified functional group or a cleavage utilizing
the following transformation reactions: oxidation, reduction, hydrolysis, and/or
acetylation (Vale, 1998). Because most of the phase 1 chemicals do not possess
enough hydrophilicity to be eliminated from the body, they must now go through
a second phase. In phase 2 the new modified chemical is conjugated (joined
together) with another substance to decrease its ability to cross cell membranes
and increase its polarity, water solubility and thus excretion from the body (Vale,
1998).
Chlorpyrifos utilizes the cytochrome P450 monooxygenases to bioactivate
the parent compound to the oxon or phosphate metabolites. Through oxidation,
the parent compound can be oxidized to form the oxon derivative, remain
unchanged, or form des-ethyl chlorpyrifos (Wessels, 2003). Each of these can
inhibit cholinesterase to form trichloropyridonol (TCP) as a by-product, which is
then usually conjugated and excreted (Wessels, 2003). However, in order for this
insecticide to biotransform into a potent anticholinesterase inhibitor, it must
convert from a thion (P=S) to an oxon (P=O) (Vale, 1998). If the phase 2 process
gets over saturated with too much of the chemical, the pathway is unable to
sufficiently transform the chemical and the level of the parent toxin builds or
enters different pathway that can result in the production of a more toxic
metabolite (Figure 1).
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Figure 1. The metabolic activation from chlorpyrifos to chlorpyrifos oxon

Chlorpyrifos is a neurotoxic agent in that it causes damage to the cells of
the central nervous system and the peripheral nervous system. The toxic action
of chlorpyrifos is acetylcholinesterase inhibition (Joesten, Netterville & wood,
1993). This chemical inhibits the enzyme acetylcholinesterase in the nerve
endings, resulting in the accumulation of the neurotransmitter, acetylcholine. If
cholinesterase activity is inhibited, acetylcholine does not break down in the
synaptic cleft leading to an excessive transmission of nerve impulses at the
neuromuscular junctions, both centrally and peripherally (Joesten, 1993). In the
central nervous system, excessive accumulation can cause sensory and
behavioral disturbances, incoordination, depressed motor function, and
respiratory depression (Ecobichon, 2001). Peripherally, overaccumulation can
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result in bronchospasm, dyspnea, bradycardia, muscle fasciculations, motor
weakness, and paralysis (Ecobichon, 2001).
In animal studies, chlorpyrifos inhibition of acetylcholinesterase activity
has been measured at doses that are much smaller than the LOso (dose
producing 50% lethality). The inhibition of acetylcholinesterase has been
measured two weeks, one month, and six weeks after exposure (Cox, 1994).
According to Cox (1994), "researchers believe that this is because chlorpyrifos is
lipophilic (attracted to the non water soluble, fatty parts of body tissues) meaning
that chlorpyrifos is stored but then released and transformed to chlorpyrifos oxon
so that effects (measured in behavioral changes) occur over a long interval"

(p.3).
Infants and children have unique characteristics that make them more
vulnerable to the toxic effects of pesticides. First, they grow and develop at a
rapid rate and any chemical exposure could result in permanent or irreversible
dysfunction (Bearer, 1995). Second, the immaturity of their metabolic pathways
leaves them unable to detoxify such chemicals (Eskenazi, Bradman & Castorina,

1999). Finally, chemical exposures early in life can result in lifelong diseases like
cancer. Of particular concern is the belief that exposure to neurotoxic pesticides
like chlorpyrifos can lead to chronic neurological diseases such as dementia or
Parkinson's disease (National Research Council, 1992). The underlying
molecular and cellular processes are vulnerable to disruption by toxicants and
can cause irreversible adverse effects on body structure and function (National
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Resource Council, 1993). The scientific community has taken a keen interest in
the adverse effects of developmental exposures and outcomes.
Developmental toxicity refers to adverse effects to the developing embryo,
fetus, or neonate. The manifestations of developmental toxicity vary according to
the timing of the chemical exposure and the underlying processes that are
occurring at that time. Those manifestations include: death of the developing
organism (embryolethality), malformation (teratogenicity), growth retardation
(embryotoxicity) and/or functional deficits (Schmidt & Johnson, 1997).
Functional deficits are of great concern because of the sensitivity of the
developing brain and central nervous system. Chemicals reach this system by
the blood circulation. Because the central nervous system is so well perfused,
lipid soluble chemicals enter the brain and exert their toxicities rapidly. Exposure
to toxins can result in a magnitude of effects from mental retardation to significant
learning disabilities. Behavioral, mental, and motor deficits are among the
possible adverse outcomes (Rogers & Kavlock, 2001).
Because chlorpyrifos is a neurotoxic chemical, the anatomical
development of the fetus and infant is extremely vulnerable to its harmful effects.
The developing nervous system begins at three weeks of gestation and is not
complete until approximately six months after birth (Eliot, 2000). With different
regions of the brain developing at different times, there are vulnerable periods
throughout neurogenesis. For example, neural tube closure occurs during early
gestation, diencephalon and cerebellum growth peak at birth and 2 years of age,
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synapse formation continues until age five, and myelination continues through
adolescence (Eliot, 2000).
Equally as important, the blood-brain barrier is not fully developed until six
months of age and even then is only partially protective to toxins (Rodier, 1995).
Prenatal chlorpyrifos exposure in rodents has been shown to inhibit DNA
synthesis and reduce brain anticholinesterase activity, resulting in significant
motor and learning deficits (Whitney, Seidler & Slotkin, 1995). Other studies have
shown that low dose exposures to chlorpyrifos during pregnancy or immediately
after birth can adversely affect the central nervous system, resulting in behavioral
changes and/or learning problems later in life (Chanda, Harp, Liu & Pope, 1995;
Hunter, Lassiter & Padilla, 1999; Muto, Lobelle, Bidanset & Wurpel, 1992;
Timchalk, Nolan, Mendrala, Dittenber, Brzak & Mattsson, 2002).

Statement of the Problem
Infants and children differ profoundly from adults and are extremely
vulnerable to environmental health hazards such as chlorpyrifos and other
pesticides. Disastrous health effects can include mental retardation, behavioral
changes, developmental delays and cognitive deficits. Unfortunately, very little is
known about the acute or chronic effects of chemicals, such as pesticides used
in the environment. As a result, the safety and well being of infants and children
may be compromised. This situation is further complicated by the multiplicity of
environmental contaminants, various exposure pathways and underlying disease
processes. Due to major knowledge gaps and a lack of consensus on causal
relationships, little is being done to study adverse health effects in humans, not to
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mention the ethical constraints associated with the use of human subjects. The
result is an uneducated public and an exacerbation of chemical exposures.
Pregnant women and nursing mothers can expose their babies without even
knowing it. Although breast-feeding is the recommended method of nutrition,
there is limited information on the types of pesticides that can be absorbed and
excreted into the breast milk. Collecting and analyzing breast milk during the
nursing stage of the infant will help in quantifying chlorpyrifos exposure.
In June 2000, the EPA announced the decision to restrict the sale of
chlorpyrifos because of the potential danger to children. As part of the phase out
agreement, retailers were to cease the sale of chlorpyrifos-containing products
after May of 2002. Unfortunately, they were free to put these products on sale to
get them off their shelves. Most importantly, retailers were not required to recall
the product or warn consumers of the potential dangers associated with product
use. In addition, farmers can obtain this product for use on certain food crops
(apples, grapes, and tomatoes) and professional pest control operators are able
to use chlorpyrifos containing products for severe termite infestations and as a
mosquitocide around homes and on golf courses.

Purpose of the Study
The purpose of the study was to determine the concentration of
chlorpyrifos in three different biological specimens: breast milk, plasma, and
saliva.
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Theoretical Framework
Environmental health hazards, such as poor air quality, lead exposure,
and pesticide exposure, can affect the quantity and quality of life. Potential
outcomes include cancer, neurotoxic effects, and functional limitations. To
understand the complex relationship between health effects and environmental
hazards, a theoretical approach is needed to guide nurse researchers toward the
goal of a health-promoting environment. An integrative model of environmental
health research has been developed by Dixon and Dixon (2002) to provide
researchers with a framework for environmental health research. The model
contains four domains of knowledge: physiological domain, vulnerability domain,
epistemological domain, and health protection domain. Each domain has a
unique interdisciplinary focus, yet all the domains are interrelated so that a
change in one domain can initiate a change in another.
The physiological domain is considered the starting point of the model.
This domain is concerned with the physiological processes and associated
human exposure effects from chemical agents in the environment. This domain
asks the question "what is the problem?" and it utilizes toxicological and
epidemiological methods of inquiry. The domain includes four elements: agents,
exposure, incorporation, and health effects. Anything capable of causing disease
is defined as an agent. Chemicals such as pesticides fall into this category.
Exposure involves contact with an agent meaning that without an exposure there
cannot be adverse effects. Pesticide exposures can occur through oral ingestion,
dermal absorption, and inhalation. In the environment, there can be multiple
25
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exposures to multiple agents however; most researchers focus on one chemical
and one type of exposure at a time. Incorporation refers to the accumulation of
the agent into human body compartments. Researchers use biomarkers to
measure accumulation and subsequent biochemical changes in the body. Health

effects are the primary area of interest in the field of environmental health.
Heavily researched areas include asbestos exposure and lung disease, lead
exposure and encephalopathy, and ozone exposure and lung cancer effects.
The vulnerability domain is concerned with the individual and community
characteristics that lead to variation in environmental health risks. This domain
asks the question "who is affected?" Individual characteristics that can affect risk
include health or disease state, gender, and development. Those persons with
preexisting disease states are particularly vulnerable since any type of chemical
exposure can exacerbate their current disease state, especially those with
chronic respiratory or cardiopulmonary conditions. Women may be especially
vulnerable due to pregnancy and reproductive physiology. Infants and children
are extremely vulnerable due to their immature organ development.
The epistemological domain is concerned with personal thought and social
knowledge as it relates to effects of the environment on health. This domain asks
the question "how does everyone know about this?" Personal thought is
associated with cognition and begins with an awareness that a potential
environmental health risk exists. Some have a lack of knowledge and are
unaware of potential risks while others have an alternate attitude in that

26

such an event could never happen to them. This domain utilizes qualitative
(ethnographies) and quantitative (surveys) as methods of inquiry.
The health protection domain focuses on those actions taken to reduce an
environmental health risk. This domain asks the question "what do people do
about it?" The elements associated with this domain are: concerns and a sense
of threat about risk and potential health effects, efficacy and confidence in the
ability to eliminate the potential risk or environmental health hazard either
through avoidance or acting as a change agent to reduce the hazard.
This model (figure 2) proposes a circular pattern in that each domain
impacts the others. Due to the enormity of environmental concerns, Dixon and
Dixon suggest concentrating on one or two domains for a research study.
Therefore, this study focused primarily on the physiological and the vulnerability
domains. With respect to the physiological domain, chlorpyrifos was the chemical
agent of choice and maternal breast milk, plasma, and saliva were the
specimens used for the exposure pathway. In the vulnerability domain, lactating
and non-lactating women were the targeted sample population.
T oxicokinetics is the study of how a chemical is absorbed into the body
and what happens following distribution of the chemical to other body organs.
This phase involves four processes: absorption (chemical enters the body),
distribution (chemical moves from the site of entry to other areas of the body),
biotransformation (the body transforms the chemical into metabolites), and
elimination (chemical or its metabolites leave the body).
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Figure 2. Conceptual model by Dixon and Dixon

Toxicology concepts were incorporated into the study for better
understanding of the dynamics concerning the use of pesticides in the
environment. Toxicokinetics is the study of how a chemical is absorbed into the
body and what happens following distribution of the chemical to other body
organs. This phase involves four processes: absorption (chemical enters the
body), distribution (chemical moves from the site of entry to other areas of the
body), biotransformation (the body transforms the chemical into metabolites), and
elimination (chemical or its metabolites leave the body).
Absorption varies greatly with different chemicals and with different
exposure pathways. The primary routes of exposure are the gastrointestinal (GI)

28

tract (exposure to residues on food products or contaminants in drinking water),
the lungs (inhalation exposure), and the skin (dermal absorption). Once a
chemical is in the bloodstream it may be excreted, biotransformed into
metabolites, which then may be excreted or moved into fat stores, or the
chemical or its metabolites may interact or bind with cellular components in
various organs. For a chemical to move within the body, it must pass across cell
membranes. Cell membranes consist of a phospholipid bilayer so that each
molecule consists of a phosphate head (hydrophilic) and a lipid tail (lipophilic).
Chemicals that are lipophilic, non-polar, and of low molecular weight are readily
absorbed through the cell membranes of the GI tract, lungs, and skin. Lipophilic
chemicals are hard for the body to eliminate and can accumulate to hazardous
levels. Most lipophilic chemicals can be transformed into hydrophilic metabolites
that can be excreted by the kidneys. When biotransformation results in
metabolites of lower toxicity, the process is known as detoxification; however,
when the metabolites are more toxic than the parent compound, the process is
known as bioactivation. Once reaching the target site, the toxicodynamic phase
occurs. This leads to a molecular biochemical response, which produces a
physiological response leading ultimately to the adverse effect in the target
organ.
Based on the above information and an extensive literature review, the
model below was developed to simplistically illustrate the various potential
pathways of chlorpyrifos exposure to the mother and the fetus or infant. In this
model there are two pathways of concern. Both pathways begin with maternal
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chlorpyrifos exposure, which is then absorbed and distributed to various parts of
the body. In the transplacental pathway, chlorpyrifos is metabolized by the liver
and then distributed to the placenta via the uterine artery. In the breast milk
pathway, chlorpyrifos is absorbed and then distributed to fat stores which are
later mobilized for milk production in the duct glands of the breast and excreted
through the breast milk. In both pathways chlorpyrifos is delivered to infant blood
circulation and then distributed to the immature brain, possibly resulting in acute
or chronic neurobehavioral effects. The following framework was used to guide
this study (figure 3).

Absorption in

Abso~oninlungs

Gltract

or skin

BloodIIymph
Circulation
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Figure 3. Conceptual model by Casey
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Delimitations

Because the study employed a form of research known as secondary
analysis, this particular study was confined to the biological specimens that were
collected for the previous research project.
Limitations

1. The majority of the participants were Caucasian. Thus the findings are
not generalizable to all lactating and non-lactating women.
2. The specimens were collected over a two year time frame and
then used for different types of analysis, therefore, subsequent
laboratory storage technique might have impacted the integrity of the
specimens.
3. Due to the associated costs of using gas chromatography,
a chlorpyrifos assay that was designed for water samples was
used for the study.
4. Because women are exposed over the lifespan to many
organophosphorus compounds that have similar chemical structures,
the assay may not be able to differentiate between chlorpryifos and
other related compounds.
5. The chlorpyrifos assay is a screening test only for which sampling
error may significantly affect testing reliability.
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6. Chlorpyrifos measurement is recorded in parts per billion, so it is
possible that the amounts in the three biological specimens were
below the level of detection.

Significance
This study attempted to determine whether the pesticide, chlorpyrifos can
be transferred into human milk and subsequently nursing infants. The enormity of
such a find is insurmountable in that nothing like this has been done to date.
There is clear evidence that these substances can accumulate and remain in the
body fat for prolonged periods of time; therefore, it is imperative that steps be
taken to prevent such exposures from occurring. The onus is on the healthcare
community to educate the public regarding the risks and potential dangers of
pesticide use.
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CHAPTER TWO
LITERATURE REVIEW
The purpose of this study was to determine the range of concentrations of
chlorpyrifos in human breast milk, plasma, and saliva. This was a concern
because of the potential of this chemical to interfere with infant development.
Few studies have assessed pesticide exposure in infants and children, and no
stud ies have examined potential adverse effects as a result of chlorpyrifos
exposure. Therefore, a broad approach to the literature was taken to establish an
empirical linkage between these concepts. The literature reviewed for this
research concentrates on two distinct areas. The first section consists of
literature that add resses the exposure pathways, specifically for the
organophosphate chlorpyrifos. The second section will address the potential
health effects associated with such an exposure. A summary of the literature
review will conclude this chapter.

Exposure Assessment
Chlorpyrifos exposure can occur through multiple routes. Exposure to
such a chemical is due to residues in food and water (oral exposure), skin
contact with contaminated articles (dermal exposure), and dispersal of aerosols
and vapors in the atmosphere (inhalation exposure). Other routes of exposure
include the transfer of chemicals from a mother's placenta (transplacental
exposure) and through the consumption of breast milk (lactational exposure).

Oral exposure. Oral exposure occurs by children eating foods
contaminated by chlorpyrifos residues. A major breakthrough in the analysis of
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pesticide dietary exposure came from a report entitled "Pesticides in the diets of
infants and children". This report was published in 1993 by the National
Research Council. According to the report, not only were children being exposed
to high levels of pesticide residues but they also had proportionately greater
dietary exposures than adults. From this report, Congress enacted the passage
of the Food Quality Protection Act in which pesticide residue levels in foods must
be found to be safe for infants and children. This act also required the
government to apply a ten-fold margin of safety to food tolerances for the
pesticide. The organophosphate class of insecticides was one of the first groups
of chemicals to be scrutinized under this new law. However, an analysis
published in 1998 by the Environmental Working Group revealed that out of the
80,000 samples of food inspected, 13 organophosphate insecticide residues
were found. Chlorpyrifos was one of the thirteen.
The Environmental Working Group study utilized surveillance data
collected by the FDA and USDA on pesticide residues from the years 1992
through 1996. The FDA has two separate surveillance programs, the FDA
Pesticide Surveillance and Monitoring Program (PSMP) and the FDA Total Diet
Study (TDS). In the PSMP program, approximately 12,000 to 16,000 food
samples are tested from all regions of the country. Unfortunately, none of the
food samples were obtained from crop growers known to have previous
violations. The second program (TDS) tests 234 different foods quarterly from
four grocery stores in one of four regions in the country. Unfortunately, the
sample size is so small that it does not appear to be representative of pesticide
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contaminants. Interestingly enough, out of 16 samples of wheat bread, all of
them were positive for chlorpyrifos, malathion (another organophosphate), or
both (EWG, 1998). The USDA Pesticide Data Program (PDP) monitors pesticide
levels in fresh fruits and vegetables. Approximately 400-700 samples are taken
from 12-14 crops per year. Unfortunately, all of the samples were washed and
peeled prior to testing which may not accurately reflect actual consumer behavior
prior to consumption. The samples with the most toxic levels of
organophosphates were apples, peaches, grapes and pears (EWG, 1998).
Chlorpyrifos has also been found as an illegal residue on food products for
which its use has been prohibited. In 1990, the FDA found detectable levels of
chlorpyrifos on fresh lettuce, a crop for which it was not registered for use. There
were nine other pesticide residues found in domestically produced lettuce
samples but the most frightening find was the chemical DOE, a byproduct from
the breakdown of DDT. Even though the U.S. banned DDT in 1972, its
persistence in the environment may account for its presence on certain food
crops (Vandeman, Shank, Chandran, & Vasavada, 1992).
Chlorpyrifos residues were also found in Cheerios. In 1994, the FDA
discovered the residues on a sample from General Mills cereal. Further
investigation revealed that a commercial pesticide applicator had illegally
sprayed 21 million bushels of raw oats with a chlorpyrifos formulation that had
not been registered for use. The fumigator pocketed $85,000 from the deal by
using chlorpyrifos since it was less expensive. General Mills sold 110 million
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boxes of the contaminated cereal before the rest was destroyed (Natural
Resources Defense Council, 1994).
In 2000, the EPA announced restrictions on the use of chlorpyrifos for
certain food crops in the U.S.; however, many other countries have no such ban.
From 1998 to 2003, chlorpyrifos residues were found on apples, oranges,
grapes, pears, and grapefruits imported from the United Kingdom. Residues
were found on 160/0 of supermarket apples and 33% of citrus fruit tested
(Pesticides Residues Committee, 2004). Tomatoes imported from Mexico also
had detectable chlorpyrifos residues in over 200/0 of samples tested (Benbrook,
2000).
Finally, chlorpyrifos residues were detected in 260/0 of freshwater fish,
which included trout and catfish. The EPA Office of Water published a report
citing the study in which fish were collected from 388 sites. The majority of the
sites were near agricultural areas, paper mills and industrial plants (1992).
Children may also be exposed to chlorpyrifos residues while exploring
their environment by putting fingers, toys, and other objects into their mouths. In
a study by Gurunathan et al (1998), two apartments were treated with a
broadcast treatment of chlorpyrifos by a licensed pesticide applicator. Plastic and
plush toys were placed on the floor one hour following the application. Residual
analyses were performed at 8,24,72, 168, and 336 hours. According to the
results, chlorpyrifos functions initially as an aerosolized particle, which is then
deposited onto various surfaces. In the next phase, it releases from the surfaces
as a vapor and is then absorbed onto the toys and furniture. The levels on the
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plastic toys peaked immediately while the plush toys sustained increasing levels
over a two-week period. The ventilation methods employed for this study were
thought to coincide with those of a homeowner following label directions. The
windows were kept closed immediately following application plus two hours. They
were then opened for four hours and then remained closed for the duration of the
study. Unfortunately, the researchers did not utilize different ventilation schemes
to determine the various chlorpyrifos concentrations if a homeowner did not
follow the label directions. Regardless, chlorpyrifos remained on absorbent
surfaces for up to two weeks following application.
Dermal exposure . .Dermal exposure occurs through skin contact with
contaminated surfaces, such as carpets, house dust, and lawns or gardens. Lu
and Fenske (1999) conducted a study in which chlorpyrifos residues were
compared from carpet and furniture surfaces following broadcast and fogger
applications. Two identical dormitory rooms were treated with chlorpyrifos, one
with a broadcast application by a licensed pesticide operator and the other with
an aerosol fogger. The ventilation techniques employed were according to
labeled instructions. The twelve subjects recruited for the study were asked to
press their hands into the treated carpet for one sample and then drag their
hands on the treated carpet for another sample. Both samples were obtained
three and a half hours following applications. These samples were then
compared to wiped samples and cloth roller samples used on furniture in the
rooms. According to the results, the transfer of chlorpyrifos from hand press and
hand drag techniques were comparable between the two applications. The
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residues from the carpet were substantially higher for the broadcast application,
but the residues found in the fogged room were substantially higher on the
furniture. Unfortunately, this study did not attempt to determine the amount of
chlorpyrifos absorbed into the body from dermal transfer.
Another potential route of exposure that can occur is through pets treated
with chlorpyrifos containing products. In a landmark study by Boone, Tyler and
Chambers (2001), two protocols were employed to determine the amount of
potential transferable residues following chlorpyrifos flea and tick dips. The first
group of twelve dogs was dipped according to the manufacturer's instructions for
four consecutive treatments at three week intervals. The other group of twelve
were dipped as above but were shampooed immediately after dipping.
Chlorpyrifos samples were obtained by rubbing the dogs with cotton gloves. Both
groups had fur samples collected prior to dipping, 4 hours after, and at 1,7, 14,
and 21 days post treatment. According to the results, for group one, the dogs
averaged 971, 157, 70, and 26 I--Ig of chlorpyrifos compared to the
shampooed dogs that averaged 459, 49, 15, and 101--19, respectively. Most of the
residues dissipated quickly after the first dipping (73-87%); however, the
researchers concluded that if a 55-pound child pets the dog for just 5 minutes
within 24 hours of the dipping, the child could be exposed to a potential dosage
of 0.027-0.057 mg of chlorpyrifos or 0.0011-0.0023 mg/kg absorbed residues.
The EPA has a safety limit of 0.003 mg/kg/day for all routes of chlorpyrifos
exposure (EPA, 1988). The above predictions were calculated according to a
geometric mean established in another study so these results reflect potential
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estimates at best. This estimate does not take into account other variables such
as surface area, the amount of clothing the child has on, or hand to mouth
behaviors of the child; not to mention the potential for inhalation vapors
associated with pet playing. Of course, most parents would not let their child play
with the family pet within 24 hours of getting dipped?1

Inhalation exposure. Inhalation exposure can occur in homes, day care
centers, schools, playgrounds, and lawns treated with chlorpyrifos. Foggers,
bombs, and aerosols appear to be the most readily inhaled due to their smaller
particle size (National Research Council, 1993). Fenske, Black, Elkner, Lee,
Methner, and Soto (1990) measured chlorpyrifos residues following a household
broadcast application for fleas. In this study, a three-bedroom apartment was
treated with a hand held broadcast nozzle by a licensed pest control operator.
Opening windows and doors ventilated two of the three rooms. Air samples were
obtained pre-application and then at five and 30 minutes, one, one and a half,
three, five, seven, and twenty-four hours post application. Chlorpyrifos vapor
concentrations (measured at 100cm above the carpet) were significantly higher
at five hours (>60J,Jg/m 3) to 24 (>40J,Jg/m 3) hours post application in the non
ventilated room and highest at seven (>10~g/m3) hours post application in the
ventilated rooms. At 25cm above the carpet (considered the infant zone), the
concentrations were significant for all three rooms at five (>60~g/m3 ventilated
and >90~g/m3 non-ventilated) to seven hours (>50~g/m3 ventilated and

>90~g/m3 non-ventilated) post application. Of most concern is that vapor
concentrations appear to peak at five to seven hours whether the rooms are
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ventilated or not, suggesting that infant/child exposure is most critical from five to
greater than 24 hours following treatment.
In 1998, Byrne, Shurdut, and Saunders were employed by
DowAgrosciences to conduct a study evaluating chlorpyrifos exposure following
crack and crevice treatment. In this particular type of application, an injector tip
was used to streamline the insecticide directly to baseboards and cracks. For the
study, the researchers used three different homes of comparable sizes and
styles. The same licensed applicator treated all three rooms. Chlorpyrifos was
applied to cracks between the baseboards and walls, under sinks, and behind
large appliances. The windows remained closed during the application.
Chlorpyrifos vapor samples were collected from the kitchen (treated) and family
room (untreated) every day for up to ten days post application. At each location,
the samples were collected at 40cm (child crawling zone) and 130 cm (standing
adult) above the floor. In house #1, levels peaked between zero and two hours
(0.76IJg/m3) at 130 cm above the floor in the kitchen. For house # 2, the peak
concentration occurred at 60-72 hours (2.3 IJg/m 3 ) and house # 3 at six to eight
hours (1.7 IJg/m3 ) post application. Both peak concentrations occurred at the 40
cm sampling height. In two of the three houses, the air concentrations declined
eight hours after the application; however, in the third house, the levels peaked
on day three and day six. The researchers are suggesting that this was due to
the fluctuation of internal temperatures; however, according to the methods
section, the air conditioning and heating remained off in an effort to maintain
constant temperatures in all three homes. The results are difficult to interpret, but
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the researchers conclude that the daily 24 hour time-weighted average for the air
concentrations at the 40 cm level were less than 1.6 IJg/m 3 which is at least five
times lower than the National Academy of Sciences guideline of 10 IJg/m3 .
Because the highest concentration lasted for only 12 hours and the air
measurements decline over a seven-day period coupled with the fact that any
actual inhaled dose would be rapidly metabolized and excreted, the researchers
concluded that it is unlikely that there would be any cumulative effects for
children following a crack and crevice treatment. Remember, the actual ceiling
dose for children is 3 IJg/kg/day from all sources!
Take-home exposures. Take-home exposures are a route of exposure

that occurs from chlorpyrifos residues that are brought home on parent's work
clothes or via farm proximity. Lu, Fenske, Simcox, and Kalman (2000) analyzed
residential contamination of organophosphates in the homes of agricultural
workers. Families were assigned to one of two groups. The first group consisted
of families with at least one member employed as a pesticide applicator (#49) or
as a farm worker (#13). The reference families comprised the second group and
their eligibility criteria stipulated that no one could work or live closer than onequarter mile to a pesticide-treated orchard (14). All samples were obtained
following the May- July spray season for tree fruit production. To analyze the
take-home exposure pathway, wipe samples were obtained from the workers
boots and the steering wheel. Hand wipe samples were obtained from the
children with ages ranging from nine months to six years. According to the
results, 38 agricultural families had detectable diethyl organophosphate residues
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on one or more wipe samples. The majority of residues were found on the work
boots. Ten out of 61 agricultural children had measurable levels of the same
residues. None of the reference families had detectable residues on any of the
samples collected. Unfortunately, there did not appear to be any determination of
time between sample collection and pesticide application. Nor was there an effort
to determine if working boots had been washed prior to the wipe sample.
A similar study was conducted by Quandt (2004) in which 41 farm families
were analyzed for pesticide residues. All of the families were Spanish and all had
at least one child under the age of seven. Wipe samples were obtained from
uncarpeted flooring, toys, and children's hands. The data collection occurred
between June and December of 2001. According to the results, 44% of the floor
samples, 29% of the toy samples and 22% of the hand samples had detectable
levels of pesticide residues. The data collection used for this study was limited to
peak spraying times.

Transpiactentai exposure. Transplacental exposure is a new concern in
infant/child exposures in that the potential transfer of chemicals from the
pregnant mother to the fetus occurs in utero. In a landmark study by Whyatt and
Barr (2000), meconium samples were collected from the diapers of 20 newborns.
All of the samples were analyzed for six organophosphate metabolites: DEP
(diethylphosphate) , DETP (diethylthiophosphate), DEDTP
(diethyldithiophosphate), DMP (dimethylphosphate),
DMTP(dimethylthiophosphate) and DMDTP (dimethyldithiophosphate).
According to the results, DEP and DETP metabolites were detected in 950/0 and
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100% respectively in the meconium samples. Both of these are metabolites of
chlorpyrifos and diazinon. Virtually none of the other metabolites were
detectable. Interestingly, the researchers had no prior knowledge of prenatal
pesticide use as the samples were collected randomly over a three-week period.
This study suggests that exposures were most likely from the second trimester
through delivery since meconium begins to collect around 16 weeks of gestation.
Bradman (2003) wanted to determine early fetal exposures at
approximately 15-20 weeks gestation by the use of amniotic fluid obtained during
amniocentesis procedures. Amniotic fluid production begins immediately
following embryo implantation and increases in volume throughout the pregnancy
(Hytten & Chamberlain, 1991). Amniotic fluid samples were obtained from 100
women who were referred for an amniocentesis in an effort to address potential
genetic disorders. Twenty samples were used for method validation, and the
remaining samples were divided into four sets of 20. The samples were then
analyzed for synthetic pyrethroids, organophosphates, and other pesticides such
as carbamates, herbicides, and chlorinated phenol metabolites. Twenty-five
percent of the organophosphate group had detectable levels of DEP, DMP, or
DMTP. Ninety percent of the samples had detectable levels of at least one
chlorinated pesticide. There were not any detectable levels of any of the
synthetic pyrethroids or herbicides in the samples. This study suggests that fetal
exposures can occur as early as 15-18 weeks gestation which correlates with
central nervous system development (Selevan, Kimmel, & Mendola, 2000).
Again, the researcher had no prior knowledge of prenatal pesticide use.
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Finally, in the Children's Environmental Cohort study (2004), pregnant
women were recruited from a prenatal clinic and two private clinics. Only
primiparas with singleton births were selected for the study, which totaled 404
participants. The researchers were interested in assessing the relationship
between prenatal pesticide exposure, paraoxonase (enzyme) activity, and infant
growth and neurodevelopment. Paraoxonase (PONI) is an enzyme that is
important in the hydrolysis and deactivation of organophosphates (Costa, Cole &
Furlong, 2003). A questionnaire was administered during the third trimester to
ascertain potential pesticide exposures. Maternal blood samples and urine were
also obtained during the third trimester, and cord blood samples were obtained at
birth. The blood samples were used to analyze paraoxonase activity in the
mother and infant. The urine samples were used to assess for the chlorpyrifos
metabolite 3,5,6-trichloro-2-pyridinol (TCP). During hydrolysis, chlorpyrifos is
detoxified and excreted in the urine as TCP. The infant birth outcomes used for
the study included weight, length, head circumference and gestational age.
Almost half of the participants (46.20/0) reported indoor pesticide use during the
pregnancy. The only significant finding was the correlation between maternal
paraoxonase activity, detectable levels of TCP in maternal urine and small infant
head circumference. It was then hypothesized that since small head
circumference has been associated with cognitive ability, chlorpyrifos could have
a detrimental effect on infant neurodevelopment.
Other studies have been done to determine pesticide exposures in
pregnant women. In 2002, Whyatt et al. conducted a study to determine pesticide
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use in pregnant women. Three hundred and fourteen African-American women
were recruited for the study of which 72 consented to personal air monitoring. A
pesticide questionnaire was administered to each woman in her home by the
same researcher. Information was obtained on demographics, smoking and
alcohol use and residential pesticide use. The 72 women that agreed to air
sampling during the third trimester was asked to wear an ambient air monitor
during the daytime hours for two consecutive days. From the questionnaire, 85%
reported use of a pesticide during pregnancy. Most household uses were by
sticky traps and gels; however, 35% reported the use of exterminators in the
home and half of the homes were sprayed more than once a month. Alarmingly,
9% reported using alternative illegal street pesticides, such as ''tempo''
(a pyrethroid) and "tres pasitos" (a carbamate). As for the personal ambient air
monitoring, 100% of the women monitored had detectable levels of three
pesticides: chlorpyrifos (range 0.7-193 ng/m 3 ), diazinon (another
organophosphate ranging from 2.0-6,010 ng/m3) and propoxur (a carbamate
ranging from 3.8-1,380 ng/m 3 ). Unfortunately, there was no prior determination of
when the pesticide was used in the home prior to the personal air monitoring.
Regardless, this is a significant finding for pregnant women'
A similar study by Berkowitz et al (2003) investigated pesticide use by 386
pregnant women. The questionnaire was also administered to the women during
the third trimester to assess the use of pesticides by a household member,
exterminator, fumigator, andlor pesticide applicator. Urine samples were also
obtained and assessed for organophosphate metabolites. According to the
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results, almost half (46%) stated that they or another household member had
applied pesticides in the home during the pregnancy. The urinary metabolite TCP
was (average 11.3IJg/g creatinine) higher than previously reported in other
studies (2.2 IJg/g in the NHANES III survey by Hill et al and 4.6 IJg/g in the
NHEXAS-MD study by Macintosh et al).

Lactational exposure. Lactational exposure is a significant route of
potential exposure in that infants can be exposed through contaminated breast
milk. Lipophilic chemicals partition into maternal adipose tissue, and are then
stored there for many years. Due to the rapid weight loss following birth, these
chemicals can then be released back into circulation and taken up into the fat of
the mammary gland (Clewell & Gearhart, 2002). Due to decades of toxic
chemicals in the environment, contamination of breast milk is widespread
throughout the country. These chemicals are stored in the fat component of the
breast milk through the process of depuration. In this process, the fat comes from
maternal fat stores and diet.
In a landmark study by Brilliant et al. (1978), polybrominated biphenyls
(PBBs) were measured in the breast milk of nursing mothers. PBBs and PBDEs
(polybrominated diphenyl ethers) belong to a family of brominated flame
retardants that are used in diverse products including electrical appliances and
computers as well as in carpets and furniture upholstery. They most frequently
enter the environment directly from broken capacitors. For instance, following the
result of an industrial accident, several thousand Michigan dairy farms were
contaminated with PBBs. These chemicals then entered the food chain through
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meat and dairy products over a two-year period. The researchers conducted a
random sample survey from 95 nursing mothers from the Upper and Lower
Michigan peninsula. According to the findings, 43% of the women from the Upper
Peninsula and 96% from the Lower Peninsula had detectable levels of PBBs in
their breast milk. The authors estimate that approximately eight million of
Michigan's nine million residents had detectable body burdens of PBBs.
In 2003, Schecter, Pavuk, Papke, Ryan, Birnbaum and Rosen analyzed
47 breast milk samples from a milk bank and community health clinic in Texas.
The milk samples were from nursing mothers between the ages of 20 and 41
years. The samples were analyzed for PBDE concentrations. According to the
findings, all of the milk samples contained various levels of PBDE
concentrations (6.2 to 419 ng/g) with a mean of 73.9 ng/g (parts per billion). The
PBDE levels did not appear to vary according to maternal age, number of
previous births, or length of lactation.
Most recently (2004), the Environmental Working Group (EWG) conducted
a survey to evaluate flame-retardants in breast milk. In their study, 20 healthy
primiparous women were recruited to participate. The women were asked to
collect a milk sample within several months following the birth of their first child
and complete an exposure assessment questionnaire intended to obtain
information concerning their lifestyle and home and work environments. The
demographic information was as follows: 1) the participants were from 14
different states in the US, 2) 18 were Caucasian, one Vietnamese, and one of
mixed races, 3) ages ranged from 29 to 40,4) 19 were college graduates, and 5)
47
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five were former smokers but none smoked during pregnancy_ According to the
results, every breast milk sample tested was contaminated with varying levels of
PBDEs (9.5 to 1078 ng/g). In addition, the researchers reported finding two of the
highest levels of PBDEs ever reported in human beings in the world (one worked
in computer related research and the other was a registered nurse). One had
recently replaced furniture cushions and the other had reupholstered dining room
chairs. None of the participants reported unusual PBDE exposure so the
variability in the PBDE levels was not easily explained by their diet, occupation,
age, body mass or amount of time they breast-fed their infants. Interestingly, 17
of the 20 participants had reported eating fish at least once per week, and 13 had
reported eating fish in the week prior to collecting the sample.
Cousins to the polybrominated biphenyl family are the polychlorinated
biphenyls (PCBs) and the polychlorinated dioxins (PCDDs) and furans (PCDFs).
PCBs were previously used mainly as heat transfer fluids in transformers while
PCDDs and PCDFs were formed primarily as byproducts following incineration
and metal smelting and refining. Wickizer, Brilliant, Copeland and Tilden (1981)
analyzed PCB levels in 1,057 nursing mothers. The samples were obtained from
68 of 83 Michigan counties of which all the samples contained PCB residues
ranging from trace amounts to 5,100 ppm (parts per million). The mean PCB
level was 1,496 ppm.
In a four-year study of PCB contaminants, Rogan and Gladen (1985)
collected breast milk samples from 856 mothers of which 43% were primiparous.
The breast milk contained almost universal contamination of PCBs and DDE.
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They also reported a decline in the PCB levels by approximately 20% after six
months with an average time for breast-feeding of 29 weeks. Unfortunately, they
did not describe the data collection or data analysis in the paper.
Additionally, in a study by Hong, Xiao, Casey, Bush, Fitzgerald and
Hwang (1994), 50 breast milk samples were analyzed for PCBs from 20 women
from the Mohawk reservation, which is in close proximity to an industrial facility,
and 30 controls who resided elsewhere. The authors reported an association
between breast milk PCB concentrations and age, parity, duration of lactation,
and cigarette smoking. Those that were older, smoked and breast-fed their first
child had higher levels of PCBs in the breast milk.
Schecter, Ryan and Papke (1998) also reported finding a decrease in
PCB concentration over the lactation period. In this study, the researchers
collected 13 breast milk samples from a mother who was nursing twins and
analyzed them for PCBs, PCDDs and PCDFs. In their findings, the PCB
concentration decreased from 285 to 63 ng/g over two and a half years whereas
the PCDD and PCDF concentrations decreased from 309 to 173 ng/kg (75%)
and 21 to 9 ng/kg (83%) respectively. The authors concluded that based on
mathematical calculations, approximately two-thirds of the PCDD concentration
was transferred to the twins. The study is obviously limited by sample size. Other
persistent organochlorine chemicals have also been found in human breast milk
such as dichlorodiphenytrichloroethane (DDT) and its metabolite (DOE), dieldrin,
heptachlor, and hexachlorobenzene (HCB). In the New York State Angler Cohort
study (1996), researchers studied breast-feeding women who consumed fish
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from Lake Ontario. The women were either licensed anglers or spouses of male
licensed anglers, and their milk samples were analyzed for PCBs, DOE, and
HCB. Nine out of 77 PCB congeners and DOE were found in all of the 100 breast
milk samples with those that consumed fish from Lake Ontario having a
significantly higher level of PCB residues than the non-fish eaters (Vena, Buck,
Kostyniak, Mendola, Fitzgerald, Sever, Freudenheim, Greizerstein, Zielezny,
McReynolds, & Olson, 1996).
Schecter, Ryan and Papke (1998) not only reported PCBs, PCDDs and
PCDF concentrations in their milk samples of the mother nursing twins but also
DOE and HCB. The DOE concentration (246 to 46 ng/g) declined by 81 % over
the 30-month lactation period. The HCB concentrations (10.7 to 1.8 ng/g)
decreased 92% over the same time period.
The only reported chlorpyrifos study was performed on maternal rats. This
report (1998) was an analysis of twelve developmental neurotoxicity stUdies
evaluated by the Office of Prevention, Pesticides, and Toxic Substances
(OPPTS). The results of the studies were summarized and compared to related
studies to evaluate prenatal development, reproduction, and neurotoxicity in adult
rats. In one of the studies, pregnant rats were administered chlorpyrifos from the
time of implantation until day ten of the lactation period. Blood and milk samples
were collected on gestation day 20 and lactation days one, five, and eleven and
then analyzed for chlorpyrifos and the two metabolites (chlorpyrifos oxon and
TCP). According to the findings, chlorpyrifos milk concentrations on lactation
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days one and five were at least ten-fold higher than maternal blood
concentrations (Makris, Raffaele, Sette, & Seed, 1998).
A recent study by Sanghi, Pillai, Jayalekshmi, and Nair (2003) of human
breast milk samples found several organophosphates including chlorpyrifos. In
this Indian study, breast milk samples were collected from 12 mothers aged 19 to
45 years. Among the mothers, three were primigravidae, and the rest had two to
five children. The breast milk samples were collected by manual expression once
the infant had nursed. Unfortunately, the authors did not provide any time line as
to when the samples were collected. The samples were then frozen at -20°C.
Data analysis was performed with the use of gas chromatography to determine t
the presence of three organochlorines and three organophosphates. Among the
various pesticide residues present, chlorpyrifos was the second highest
concentration found in the breast milk samples. In addition, all 12 samples
contained varying residue levels of chlorpyrifos.

Biomarkers of Exposure
Because fetuses, infants and children have so many potential exposure
routes, biomarkers have now become the benchmark for determining such an
exposure. Biomarkers for determining organophosphate exposure typically
include cholinesterase inhibition (De Peyster et ai, 1993; Lessenger & Reese,
1999; Vandekar, 1980) in blood and metabolites in urine (Adgate et ai, 2001;
Castorina et ai, 2003; Fenske, 2002; Loewenherz et ai, 1997; Lu et ai, 2001;
Mills, 2001). As noted earlier, organophosphates undergo chemical changes in
the human body. The first reaction for chlorpryifos occurs in the liver where the
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double bond of the central phosphorus atom transforms from sulfur to oxygen. It
is now a considered an "oxon" and is a much more potent inhibitor of
cholinesterase enzymes. This process can be measured in red blood cells by
determining the reduced cholinesterase activity or AChE in the blood.
Unfortunately, AChE levels can vary between individuals and can fluctuate within
individuals as a result of health conditions, such as pregnancy, diseases,
medications, and illegal drugs (Lessenger & Reese, 1999). In addition, large
doses of chemicals are required for significant inhibition to occur resulting in an
insensitivity to low exposure levels (He, 1999). Chlorpyrifos can b~ measured
directly in the blood by way of plasma or serum; however, because chlorpyrifos
metabolizes in 24-48 hours, it is unlikely that sample collection would coincide
with the exposure (WHO, 1996).
The second chlorpyrifos reaction that occurs is hydrolysis which yields a
diakylphosphate and a leaving group. This metabolic reaction is known as
detoxification as it is easily excreted in urine as the metabolite TCP. The difficulty
in measuring this metabolite and other organophosphate metabolites is related to
the concentration of the urine. Most laboratories will normalize the concentration
by using creatinine clearance or specific gravity; however, in children, this can be
quite variable (O'Rourke et al., 2000).
Newer methods such as that of testing meconium (Whyatt & Barr, 2002),
amniotic fluid (Bradman, 2003), saliva (Timchalk et ai, 2004) and breast milk are
serving as biomarkers of the future. "The use of meconium shows promise and
further research could firmly establish it as a biomarker for organophosphate
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exposure" (Wessels, 2003). Breast milk is an appropriate biomarker for exposure
because chemicals (especially those that are extremely lipophilic) can
accumulate in the fatty tissues for a number of years.
Effects Assessment
Due to the vulnerability of fetal, infant and child development, the brain
and the nervous system are especially sensitive to the effects of neurotoxic
chemicals, such as the organophosphate chlorpyrifos. Other manifestations of
toxicity includes fertility problems, spontaneous abortion, fetal death, birth defects
and delayed growth. Most of this evidence comes from animal studies that
examined developmental neurotoxicity. The precise nature of these effects
depends on the amount of the dose received, the toxicological properties of the
chemical and the timing of the exposure with the critical windows of fetal, infant
and child development.
Animal studies are done by exposing various animals to a chemical and
then evaluating the effects of such an exposure. In a landmark study by Muto,
Lobelle, Bidanset and Wurpel (1992), pregnant rats were given chlorpyrifos on
days 0 to 7 or days 7 to 21. For both groups, the rats were randomly assigned to
receive 0.03 mg/kg, 0.1 mg/kg, 0.3 mg/kg or saline. Following delivery, the rat
pups were evaluated for viability, birth weight, and general physical
characteristics. They were then re-evaluated on day 16 for behavioral
abnormalities and neurotoxicity. In another study, rat pups were either given
0.1mg/kg or 0.3 mg/kg on postnatal days 3, 10, or 12 for group one and daily on
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days 6-10 for the second group. Both groups were then observed on day 16 for
behavioral abnormalities and neurotoxicity.
For the neurotoxicity evaluation, a rotating rod on which pups had to
balance was used to determine the number of falls, with comparison between the
two groups of chlorpyrifos versus saline. The incline test was used to determine
motor activity, and general motor behavior was assessed using open field
observation. The pregnant females that received the chlorpyrifos injections did
not exhibit any overt signs of toxicity; however, all three chlorpyrifos doses
caused a greater number of abnormalities than those pups that received saline.
For the 0 to 7 day group, chlorpyrifos caused 770/0, 57% and 680/0 lethality and
15%,66°.4> and 55% physical abnormalities. For the 7 to 21 day group,
chlorpyrifos caused 17%, 22% and 38% lethality with only the latter dose causing
any physical abnormalities. None of the pups from the saline infused groups had
any lethalities or abnormal physical characteristics. Rat pups given 0.3 mg
chlorpryifos!kg prenatally demonstrated significant neurotoxicity on postnatal day
16 as well as those pups that received chlorpryifos on postnatal days 3, 10, or
12.
Chanda, Harp, Liu and Pope (1995) also demonstrated neurobehavioral
effects in rat pups following chlorpyrifos injections. In their study, pups were
place in a supine position and then measured to determine their ability to turn
over (known as the righting reflex). Chlorpyrifos exposure greatly altered this
reflex on postnatal day one. In a different study, Chanda and Pope (1996) found
that repeated chlorpyrifos exposures in rats during pregnancy resulted in
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inhibited levels of AChE. Whitney, Seidler and Slotkin (1995) demonstrated that a
single dose of chlorpyrifos given to one-day-old rats could cause significant
inhibition of DNA synthesis in all brain regions within four hours of treatment.
Human studies are done to assess the potential effects of chemicals after
the exposure has occurred. Steenland et al. (2000) conducted neurologic tests
on pest control operators who had worked as termiticide applicators from 1987
1997 in 12 counties of North Carolina. Those that had worked for a year or more
were recruited for the study until 200 participants were selected (exposed group).
Half of these subjects were asked to bring a friend to serve in the nonexposed
group. Another 100 state employees were recruited as well for a total of 200 in
the nonexposed group. All participants were given the Neurobehavioral
Evaluation, which consisted of a vibrotactile test, arm/hand tremor test, postural
sway test, manual dexterity test, eye-hand coordination test, vision test, olfaction
test, nerve conduction velocity, and neurological exam. In addition, the
participants were given a questionnaire to assess neurologic symptoms. Urine
and buccal swabs were taken to measure TCP and paraoxanase, respectively.
In the exposed group, 191 termiticide applicators who had an average of
2.4 years applying chlorpyrifos were compared to 189 non-exposed participants.
The two groups did not differ significantly in the neurological exam; however, the
exposed group did not function as well as the non-exposed group on a few of the
neurobehavioral tests (postural sway test and the pegboard turning test). In
addition, the exposed group reported significant differences on the questionnaire
complaining more memory problems, emotional mood states, fatigue, and loss of
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muscle strength. Those applicators that had more recent chlorpyrifos exposures
had higher levels ofTCP (629.5 ug/ L) in their urine than the other applicators
(4.5 ug/L).
Kaplan, Kessler, Rosenberg, Pack and Schaumburg (1993) conducted a
retrospective analysis of eight people exposed to chlorpyrifos following
commercial application by professional exterminators. All eight report peripheral
neuropathy while five of the eight experienced memory loss and cognitive
slowing. The authors concluded that environmental contact with chlorypyrifos
could cause sensory neuropathy and central nervous system dysfunction. This
study is extremely limited by the small sample size.
Zweiner and Ginsburg (1988) reviewed the medical records of 37 children
that had been diagnosed with organophosphate toxicity. The ages of the patients
ranged from one month to 11 years. A little more than half of the children were
boys, and 62% of the poisonings occurred from April through September. All of
the poisonings occurred at home and six cases involved chlorpyrifos. Ingestion of
stored liquid was involved in three-fourths of the cases, and playing on the carpet
or floor following application was involved in 14% of the cases. The most
common signs and symptoms included miosis (73%), excessive salivation (70%),
muscle weakness (680/0), respiratory depression (590/0), lethargy (540/0), and
tachycardia (490/0). Three of the six chlorpyrifos cases were life threatening due
to coma or respiratory arrest (Blondell, 1999). There were no deaths, and
everyone recovered promptly following therapy.
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Sherman (1996) reported four cases of birth defects associated with
chlorpyrifos poisoning. The obstetrical history was reviewed in all four cases for
incidence of infections, alcohol and/or illicit drug use, medications and smoking.
Other evaluations included chromosomal analyses, family pedig rees and records
of treating physicians. The only common element found in all four cases involved
chlorpyrifos exposure during the pregnancy. Three of the mothers were exposed
at home, and the fourth was exposed at work. Child #1 and child #3 are siblings
and were both exposed to chlorpyrifos after the family used a flea fogger with
child #1 and used a commercial operator who applied chlorpyrifos in the home
with child #3. The mother of child #2 was exposed late in the first trimester after
treating the home with chlorpyrifos, and the mother of child #4 was exposed at
work early in her first trimester. According to the author, all four children had
ventricular, eye, and palate defects as well as growth retardation. Three of the
four children had hydrocephaly, microcephaly, mental retardation, blindness,
hypotonia and other limb defects. Brain defects were remarkable for
structural defects of the corpus callosum in two children, an enlarged chloroid
plexus in one child and absence of the septum pellucidum in the fourth child. The
author suggests that the pattern of defects in all four children is conclusive
enough to warrant further investigation of chlorpyrifos as a common cause of
teratogenic effects.
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Summary
There is ample evidence in the literature that chlorpyrifos poses a
significant threat to fetuses, infants and children. The various pathways of
exposure are well documented as well as the potential for developmental
neurotoxicity in animals and humans. However, what is lacking is the
documentation of chlorpyrifos as a vehicle for transport from the lactating mother
to the nursing infant and the subsequent effects, if any, in the infant or child.
Even though the EPA has banned chlorpyrifos for home use, it is still being used
agriculturally and by professional pest control operators as they see fit. Until
more is known about the developmental effects of these chemicals, continued
research is imperative. Although most experts agree that breast -feeding is the
preferred nutrition for nursing infants, studies are needed to evaluate pesticide
exposures through breast milk in order to protect the infant from adverse effects.
With this type of information, breast milk monitoring programs could be put in
place to educate those populations at risk for chlorpyrifos exposure and potential
toxicity.
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CHAPTER THREE
METHOD
The purpose of this study was to determine the concentration range of
chlorpyrifos in human breast milk, plasma, and saliva. The research method
employed for this study was an analysis of existing samples collected for the
purposes of a prior study. The study design, sample, setting, protection of human
subjects, instruments used, data collection, and data analysis will be described
below.

Study Design
Evidence suggests that women are being exposed to environmental
chemicals such as chlorpyrifos; therefore a quantitative methodology was to
guide this study. With this approach, biological samples can be collected
(empirical evidence) to obtain numeric information about chlorpyrifos
concentrations that can then be analyzed by statistical procedures. Due to the
ethical issues associated with testing humans for chemical effects, non
experimental studies are the most common research methods for collecting data
of this nature. The most logical design for this type of study would be that of a
longitudinal nature. Once the basic question of exposure has been answered,
then effects of chemicals on factors such as neurobehavioral indicators could be
measured over a specified unit of time. Theorizing that chlorpyrifos exposures will
have developmental effects on fetal organs, such as the brain, there is a
possibility that negative cognitive and behavioral indicators might not present
themselves for months or even years to come. Although this researcher would
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favor this type of research design, due to time constraints associated with a
dissertation proposal, such a study was not feasible. Taking into consideration
the element of time, a more feasible option was that of the cross-sectional
design. This type of design is used when there is a desire to obtain information in
an area about which little previous research has been done. According to Polit
and Hungler (2002), "cross-sectional data can most appropriately be used to infer
temporal sequencing under two circumstances 1) when there is evidence or
logical reasoning indicating that one variable preceded the other, and 2) when
there is a strong theoretical framework guiding the analysis" (p. 162). This
particular type of method fit this research design well in that logical reasoning
implies that a mother must first have been exposed to chlorpyrifos so that the
concentration can then be measured in the breast milk.
However, for chemical exposure studies, the route, timing, and extent of
the exposure are often difficult to determine (Clewell & Gearhart, 2002). Virtually
all exposure studies collect historical information regarding pesticide use, which
are usually answered through questionnaires or interviews. Fenske, Bradman,
Whyatt, Wollfe, and Barr (2005) found that subjects were best able to provide
general information regarding the use of products, as in controlling weeds or
insects, but not necessarily able to provide detailed information on specific
chemicals. According to these researchers,
In preliminary analyses of questionnaires administered by the Columbia
center, women provided a pesticide product name for only 39% of the
pest control methods reported to be used in the home during pregnancy
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and, in particular, were very rarely able to identify the pesticide products
used by an exterminator. Further, pesticide products can have the same
brand name but contain different active ingredients, further complicating
use of questionnaire data in pesticide exposure assessments. In addition,
the Mount Sinai center collected urine samples in the 3 mtrimester of
pregnancy, and found that approximately 70% of the women in the cohort
had been exposed to pesticides, but no associations were found between
the biological levels and pesticide questionnaire data.
The researchers concluded that it is highly unlikely that questionnaire data alone
can prove adequate for identifying pesticide exposure of women during
pregnancy (2005).
According to the National Children's Study (2005), pesticide exposures to
the general population may be very difficult to assess because humans are
generally exposed to low levels of environmental chemicals all the time, the
exposures may occur without prior knowledge, and they may occur through a
multitude of routes or pathways. Therefore, when assessing pesticide exposures,
there is no single method that will capture all the needed exposure information all
the time (Needham et ai, 2005).
Another concern is related to the subject matter of this particular study, in
that the determination of chlorpyrifos residues present in maternal breast milk
may be of extreme concern to nursing mothers. Mothers will want to know not
only if the chemical is present but also the potential ramifications associated with
such a find. In addition, the potential horror those mothers may experience when
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learning that they may have inadvertently poisoned their babies could be in and
of itself a potential crisis. Due to the above concerns, a less obtrusive research
method known as secondary analysis was employed for this study.
Secondary analysis involves the use of existing samples, collected for the
purposes of a prior study in order to ask a new research question that is distinct
from that of the original work (Hinds, Vogel, & Clarke-Steffen, 1997). This type of
analysis can be used to generate new knowledge or new hypotheses. The
advantages to using secondary analysis are that it reduces the burden of subject
recruitment and data collection and it allows wider use of data from potentially
inaccessible respondents. The study partiCipants were told that the purpose of
the original study was to learn more about stress and health during the early
postpartum period. The benefits of the original study were to gain more
knowledge about stress, health and immune function in lactating versus non
lactating postpartum mothers.

Sample Design
The original research study explored the influence of lactation on stress
and immunity in postpartum mothers. This was a non-experimental, cross
sectional study funded by the National Institutes of Health. The specific aims of
the study were: 1) to analyze perceived stress, stressful life events, mood states,
levels of stress-associated hormones, and relationships among these variables in
lactating compared to non-lactating women; 2) to analyze immune variables and
occurrence and severity of symptoms of common infections in lactating
compared to non-lactating women; 3) to analyze relationships between stress
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and mood variables, immune variables, and incidences and severity of symptoms

1

L

of common infections in lactating and non-lactating women. The researchers
measured levels of stress hormones (oxytocin, prolactin, cortisol), type 1 and 2
cytokines, enumeration of selected lymphocyte subsets, proliferative responses
of lymphocytes, levels of stress hormones, neopterin and immunoglobulin A
concentrations in saliva.

Sample
A power analysis was conducted to determine the appropriate sample size
needed to increase the likelihood of demonstrating significant results. For a
power of 0.80, a significance level of 0.05 and a medium size effect (r=. 3), a
sample size of 80 subjects for each group would be sufficient. Therefore, the
researchers recruited 100 lactators and 100 non-Iactators for the study.
Subjects were recruited from the postpartum unit of a local hospital,
through the health department, and participating OB/GYN offices at the time of
their first postpartum visit. The subjects were healthy mothers between the ages
of 18 and 45 years old who were four to six weeks postpartum after delivery of a
full term infant by an uncomplicated vaginal or cesarean delivery. Exclusion
criteria included the following: under 18 or over 45 years of age, chronic mental
or physical illnesses, medications that could influence immune function, serious
complications during pregnancy, labor, or delivery. The subjects were visited
either in their homes or at their health care providers office between four to six
weeks postpartum. At the visit, the investigators collected the study
questionnaires, breast milk (from lactating group), saliva, and blood samples.
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The milk, saliva, and serum samples were placed on ice and transported to the
lab within two hours of attainment. The serum was spun, aliquoted, and frozen at
-20°C. The milk was spun at 6000 rpm, aliquoted and also frozen at -20°C.
For the purposes of this dissertation, this researcher chose 52 subjects
from the original study for use in a secondary analysis. The subjects were
selected based on the availability of biological specimens. In the lactating group
there were 26 each of matched breast milk, plasma and saliva samples and in
the non-lactating group there were 26 matched plasma and saliva samples. A
two group design was chosen to compare differences in plasma and saliva
chlorpyrifos concentrations. Based on the literature, these two concentrations
should be higher in the lactation group.

Setting
As mentioned previously, this researcher chose 26 lactating subjects and
26 non-lactating subjects for secondary analysis of breast milk samples, serum
samples and saliva samples. The analysis was conducted at the Walker
Research Laboratory in the College of Nursing, University of Tennessee,
Knoxville, under the direct supervision of Dr. Maureen Groer. This researcher
performed all the analysis of the biological specimens.

Protection of Human Rights
Subjects were invited to participate in the original study through notices
posted at the University of Tennessee Medical Center, the Knox County Health
Department, and in participating physician offices. Nurses were available at all
locations to describe the purpose of the study and to answer any potential
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questions. Once they agreed to participate in the study, a written consent was
obtained. The participants were given a packet that included an information sheet
about the study, potential risks and benefits, data collection procedures, notice of
rights to withdraw from the study at any time, email address and telephone
number of the researcher, and a $50 gift certificate. To insure confidentiality, no
names were attached to any specimens, questionnaire forms, or instrument
packets. All of the completed forms and specimens are kept in the Walker Lab,
which is locked at all times.
For purposes of the secondary analysis study, this researcher maintained
confidentiality by assigning numbers to the questionnaires and biological
specimens. The groups were categorized as lactators and non-Iactators.
The information from the analysis was kept in a locked cabinet at the researchers
home. Any published material will only contain the above information.

Instruments
The demographic tool was the only instrument accessed from the original
study for use in this study. This questionnaire included information on age, race,
height and weight, yearly income, family size, work status, exercise, presence of
any acute or chronic health problems, smoking, medication use. It also included
information on labor history, birth history, postpartum complications, and breast
feeding or bottle-feeding status.
Biological testing has become the template for determining human
pesticide exposure. Because pesticide exposures have multiple routes,
biomarkers tend to integrate all the various pathways. The analysis is done by
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estimating the amount that is absorbed into the body and then measuring the
pesticide itself, its metabolite, or its reaction products in biological media, such as
urine, blood, saliva, meconium, and breast milk (Barr & Needham, 2002). Most
persistent pesticides are best measured in such media as a result of their long
biological half-lives and ability to sequester into lipid rich matrices. According to
Barr and Needham (2002), because of the long half-lives of persistent pesticides,
it is usually difficult or impossible to distinguish recent exposures from exposures
that occurred decades ago. One possible indicator of a recent exposure may be
a level elevated above the range that is normally seen. However, many
chemicals and/or their metabolites are present in different concentrations in
different types of biological media.
The most common biospecimen for use in analyzing chemical exposures
is urine. Such analysis is due to its ease in availability, the volume, and
potentially higher concentrations (ug/I or parts per billion) as compared to blood
concentrations (ng/l or parts per trillion). Unfortunately, the measurement is most
often a metabolite of the parent compound. The other disadvantage to using
blood for biosampling relates to the volume variability. Adjustments are required
to correct for dilution issues, which often use creatinine concentrations. In the
case of chlorpyrifos, there are several metabolites, such as DEP and DEPT,
\that are the same metabolites as other organophosphates. The only metabolite
that is specific to chlorpyrifos is TCP. The half-lives of chlorpyrifos and its
metabolites in urine are 15 to 30 hours (Griffin et at, 1999). In the Minnesota
Children's Pesticide Exposure Study (2000),102 urine samples were collected
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from children aged 3 to 13. TCP was present in 930/0 of the samples. The
metabolite TCP has been measured in urine as low as 0.5 ppb with a
concentration range of 0.5 to 340 ppb of urine (Barr et ai, 2004a; Berkowitz et ai,
2004; Chang, Lin, Lo, & Lin, 1996; Eskenazi et ai, 2004; Fenske, Lu, Barr, &
Needham, 2002; Krieger et ai, 2001; Morgan et ai, 2004). Unfortunately, urine
samples were not obtained from participants in the original study from which
samples used in this study were derived.
Measuring pesticides in blood is advantageous in that the parent
compound, or its metabolites, can be directly measured in plasma and
serum. Furthermore, because blood is a regulated fluid and does not vary
markedly with water intake or other factors, no corrections for dilution are
necessary (Barr & Needham, 2002). The half-life of chlorpyrifos in blood is 24
hours (Nolan, Rick, Freshour, & Saunders, 1984). Chlorpyrifos concentrations
have been detected in maternal and cord blood plasma with a range of < 1 to 10
ppt (Whaytt et ai, 2003; Whayett et ai, 2004). Chlorpyrifos metabolites have also
been detected in plasma ranging from 0.1 to 2.8 ppm (Drevenkar et ai, 1994).
Because chlorpyrifos is a potent inhibitor of acetylcholinesterase, the
inhibition of cholinesterase is believed to be the most sensitive tool for evaluating
exposure (Abdollahi, Mood, Akhgari, Jannat, Kebriaeezadeh, & Nikfar, 1996).
This effect can be measured in red blood cells (AChE) and plasma (PChE).
However, due to fluctuations in acetylcholinesterase levels, a baseline is usually
required to determine if suppression has occurred (International Biomonitoring
Workshop, 2004). Another disadvantage to AChE monitoring is that high
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exposure levels are normally required to indicate acute toxicity and since most
exposures are more likely to be intermittent, AChE might not be an appropriate
measuring tool for chronic exposures (He, 1999). However, De Peyster, Willis,
Molgaard, MacKendrick, and Walker (1993) found a high correlation between
self-reported pesticide exposure and plasma cholinesterase activity for 203
pregnant women.
Saliva has recently received attention as a possible matrix for measuring
pesticides. Scientists at the Department of Energy's Pacific Northwest National
Laboratory found very low concentrations of chlorpyrifos in rat saliva (Kousba,
Poet, & Timchalk, 2003). The researchers used a modified assay to assess
salivary cholinesterase in male rats. In addition, Denovan, Lu, Hines, & Fenske
(2000) reported saliva measurements of the herbicide atrazine in human
pesticide applicators. The obvious attraction to this type of analytical
measurement is that it is easy, cost-efficient and non-invasive.
Breast milk has been shown to be an excellent source for evaluating
pesticide exposures. Many organochlorine compounds have already been
documented in human breast milk; however, there is only limited data available
on any of the chemicals in the organophosphate class, especially chlorpyrifos. In
a study by Mattson, Maurissen, Nolan, and Brzak (2000), chlorpyrifos and
chlorpyrifos oxon analyses were conducted on milk from female rats that were
exposed to chlorpyrifos via gavage. The samples were taken on lactation days
one, five, and eleven. According to the authors, not only were chlorpyrifos milk
concentrations up to 200 times those in blood but also nursing pups had a
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measurable exposure to chlorpyrifos via the milk. Chlorpyrifos has also been
detected in human breast milk according to a study from India. The mean
chlorpyrifos concentration in 12 breast milk samples obtained during the first
month of lactation from Indian women was 230 ug/L (ppb) with a range of 85 to
355 ug/L (ppb) (Sanghi, Pillai, Jayalekshmi, & Nair, 2003).
Scientists have been using gas chromatography for pesticide analysis
because of its ability to detect low levels at extremely low concentrations;
however, this particular type of method is expensive and requires skilled analysts
for sample preparation. The need for rapid, cost effective monitoring methods to
assess human exposures to environmental contaminants such as chlorpyrifos
have been brought to the forefront by various research laboratories.
Immunochemical methods such as immunoassays provide information regarding
the presence and concentration levels of various environmental contaminants.
This analysis is more time efficient and cost effective than other laboratory
analyses such as gas chromatography.
Immunoassays, used to detect and quantify many various types of
molecules, which vary widely in size, chemical properties and biological activity,
are sensitive, accurate, and reproducible. Most pesticides are rather small
molecules and are typically less than 1,000 atomic mass units. Unless they are
bound to an antigen, they will not bind to a specific antibody. Therefore, they
must be conjugated to a larger protein molecule before they can be used as
antigens. Fortunately, several research laboratories have developed selective
enzyme-linked immunosorbent assays (ELISA) for specific insecticides. These
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ELISAs are based on selective antibodies combined with enzyme reactions to
detect low levels of chemicals and was the method of choice used in this study.
Chlorpyrifos RaPID Assay utilizes the principles of an immunoassay
developed for the purposes of chlorpyrifos detection in water, wastewater, cereal
grains, bananas, and soil. Even though the method had not been used for
biological samples, the ease of the test and the minimal cost of the assay made it
extremely attractive. A test kit was purchased from Strategic Diagnostics Inc. and
a pilot test was run on five samples each of plasma, saliva and breast milk that
were spiked with varying amounts of chlorpyrifos. Based on previous human
biological studies of chlorpyrifos, this researcher spiked the samples with 0.1,
0.5, 1.0, and 5.0 nanograms per milliliter (parts per billion) (Drevenkar et ai,
1994; Sanghi et ai, 2003 & Whyatt et ai, 2004). The lowest concentration of
chlorpyrifos the assay was able to detect was 0.1 ppb with a linear range was
0.22 to 3.0 ppb. The assay is approximately eight times more sensitive to
chlorpyrifos than any other related compound.
The assay applies the principles of an ELISA (enzyme linked
immunosorbent assay) by relying on antibodies that specifically detect
chlorpyrifos and related compounds. To begin the test, 250 micrograms of
standards (0.22, 1.0, and 3.0), control, and samples are placed into labeled test
tubes. Chlorpyrifos enzyme conjugate (horseradish peroxidase labeled
chlorpyrifos analog of HRP) is added to the test tubes followed by 500
micrograms of paramagnetic particles. The chlorpyrifos antibody (mouse
monoclonal anti-chlorpyrifos) is covalently bound to paramagnetic particles,
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which are suspended in buffered saline. Both the chlorpyrifos in the sample and
the HRP labeled chlorpyrifos compete for the binding sites on the antibody bound
to the magnetic particles. Following incubation, a magnetic field is applied to hold
the paramagnetic particles in place, which allows the unbound reagents to be
decanted. After the decanting, the particles are washed with deionized water.
The presence of chlorpyrifos is detected by adding a solution of hydrogen
peroxide and chromogen (3,3', 5'5'-tetramethylbenzidine) in an organic base.
These react to form a colored product. Following a second incubation, this
reaction is stopped and stabilized by the addition of sulfuric acid.

In the pilot

test, the colorimetry results were evaluated with a photometer, which measures
optical density (0. D.). Optical density values were then utilized to estimate
chlorpyrifos concentrations using the standard curve O. D.s, with the GraphPad
Prism software. All three biological samples responded accordingly in that the
concentrations followed an appropriate linear curve based on the amount of
chlorpyrifos spiked in the sample. The inter assay coefficients of variation for the
breast milk samples were 18.56%. Based on this information, more kits were
purchased for analysis of the three biological specimens.
Data Col/ection

In the original study, once the participants volunteered to participate in the
study, a packet of instructions, instruments, and containers were mailed to their
home address. Between four and six weeks postpartum the mothers were either
visited during the morning in their homes or at their health care providers office
by one of the trained investigators. On the morning of the visit, according to the
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instructions, mothers were to collect a saliva sample and a milk sample (if breast
feeding). For the saliva sample, they were instructed not to eat, smoke or brush
their teeth one hour prior to collection. The timed five-minute saliva specimen
was collected by drool methods into a container. For the breast milk sample, the
mothers were instructed to wash their hands with an antimicrobial soap before
collection. They were to collect five milliliters (approximately one teaspoon) of
milk, either by hand or by use of a breast pump, after they finished nursing. This
sample was to be immediately placed in the refrigerator. Once the trained
investigator arrived, ten milliliters of venous blood was obtained by antecubital
venipuncture and immediately placed on ice. Once the biological samples and
paperwork were obtained, they were transported on ice to the laboratory.
For this study, the assays were run in batches. At the time the assays
were run, the chlorpyrifos kit and the specimens were allowed to thaw to room
temperature. The standards, control, and specimens were set up in duplicates for
all the batches for a total of 26 breast milk samples, 52 plasma samples and 52
saliva samples (26 each for lactating and non-lactating subjects). The
Chlorpyrifos RaPID Assay was performed according to the manufacturers
instructions. Absorbance was measured using a photometer with a wavelength
of 450 nm.

Data Analysis
Descriptive statistics were used to describe the sample characteristics and
demographic variables of the sample population. Descriptive statistics were also
used to compute the mean, mode and median of the chlorpyrifos concentrations
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in all three biological samples. Tests for normality were conducted to determine
whether parametric or non parametric tests were appropriate for statistical
analysis. The variables requiring log10 transformation were plasma and saliva
chlorpyrifos concentrations for positive skewness.
To examine for relationships between milk, plasma, saliva and the other
variables, such as age, weight, height, race, income, work, number of
pregnancies, number of live births, marital status, smoking, use of prescription or
herbal medications and number of weeks postpartum at the time of data
collection, a correlation matrix was performed. The Pearson Product Correlation
and the Spearman Rho Correlation were both used according to the level of data
measurement. An alpha level of .05 was the criterion used for statistical
significance. All data analyses were conducted with the SPSS software program.
To determine if there were any differences between the lactating and non
lactating groups, a t-test between the means was performed using the
independent samples t-test. The t-tests were run on plasma and saliva for both
groups. An alpha level of .05 was the criterion used for statistical significance.

Summary
Sio monitoring or testing humans for pollutants is performed on urine,
meconium, amniotic fluid, blood and saliva. Sometimes those particular samples
can be invasive and harder to acquire. Human breast milk is easy to obtain, less
intrusive, and can provide much needed information on environmental chemicals
deposited and retained in fat reserves. This chapter discussed the methods and
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CHAPTER FOUR

I

RESULTS
!

The purpose of this study was to determine the concentration range of
chlorpyrifos in human breast milk, plasma, and saliva in lactating mothers as
compared with plasma and saliva in non-lactating mothers. In this chapter the
findings of the study will be presented in three sections. The first section will
describe the sample demographics. The second section will report the
chlorpyrifos concentrations in the breast milk, plasma, and saliva samples in the
lactating group. The third section will report the chlorpyrifos concentrations in the
plasma and saliva samples in the non-lactating group.
Sample Demographics
Based on biospecimen availability, there were a total of 26 subjects each
for the lactating and non-lactating groups. For the lactating group there were 26
breast milk samples, 26 plasma samples and 26 saliva samples. The nonlactating group had 26 plasma samples and 26 saliva samples. The mean,
standard deviations and range were used to describe the variability in the
samples.
Tests of normality were performed on the means of all three biological
samples, the breast milk, plasma and saliva. The milk variable was normally
distributed. (Figure 4) However, the plasma and saliva variables were positively
skewed. After verifying the data entries, four plasma chlorpyrifos values and
three saliva chlorpyrifos values were identified as greater than three standard
deviations from the mean and were therefore deleted (Figures 5 and 6).
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It is important to note that 7 out of 52 plasma and saliva concentrations
were extremely high and were therefore deleted. This could be a significant
finding in that those seven subjects could have had acute chlorpyrifos exposures
resulting in abnormally high levels. This could be a significant finding in and of
itself.
The mean age for the lactating group was 28.28 years +/- 5.899 SO
(range 19 to 38). The mean weight was 168.53 pounds +/- 40.31 SO (range 132
to 320) and height was 66.12 inches +/- 3.00 SO (range 60 to 72). There was one
African American and one Hispanic in the lactating group; the rest were
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Caucasian. The mean income was $30,000 to $40,000 +/- 1.41 SD (range
<10,000 to >40,000). The majority of the subjects did not work (15 out of 26), 2
worked part time and 9 worked full time, and the majority of them were married
(22 out of 26 married, 4 single). The mean number of pregnancies was 2.16 +/
2.19 SD (range 1 to 12), and the mean number of live births was 1.85 +/- 1.43
SD (range 1 to 8). There were two subjects who smoked, eleven who used
prescription medications and six who used herbal medications. Seven of the
subjects had cesarean sections, and the rest were delivered vaginally. The mean
for the number of weeks postpartum at the time of data collection was 5.16 +/
.845 SD (range 3.6 to 7.0) (Table 1).

Table 1. Demographic statistics for lactating group
Descriptive Statistics
N
Age
Weight
Height
Pregnancy
Live births
Marital
Smoke
Prescription meds
Herbal meds
Weeks postpartum

25
19
25
25
26
26
26
26
25
26

Minimum

Maximum

19
132
60.00
1
1
0
0
0
0
3.6

38
320
72.00
12
8
2
2
25
1
7.0

Mean

28.28
168.53
66.1200
2.16
1.85
1.81
1.04
1.38
.24
5.162

Std. Deviation

5.899
40.310
3.00444
2.192
1.434
.491
.344
4.842
.436
.8457
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The mean age for the non-lactating group was 22.84 years +/- 4.35 SO
(range 18 to 35). The mean weight was 162.05 pounds +/- 32.39 SO (range 105
to 205) and height was 64.15 inches +/- 3.12 SO (range 58 to 70). There was one
African American in the non-lactating group, and the rest were Caucasian. The
mean annual income was $10,000 to $20,000 +/- 1.31 SO (range <10,000 to
>40,000). The majority of the subjects did not work (19 out of 26), 4 worked part
time and 3 worked full time), and the majority of them were married (14 out of
26), 11 were single and 1 divorced. The mean number of pregnancies was 1.96

+/- .841 SO (range 1 to 4), and the mean number of live births was 1.81 +/- .749
SO (range 1 to 3). There were ten subjects who smoked, four who reported
current health problems, six who used prescription medications and one who
used herbal medications. Six of the subjects had cesarean sections, and the rest
were delivered vaginally. The mean for the number of weeks postpartum at the
time of data collection was 5.15 +/- .914 SO (range 4.1 to 7.5) (Table 2).

Table 2. Demographic statistics for non-lactating group
Descriptive Statistics
N
Age
Weight
Height
Pregnancy
Live births
Marital
Smoke
Prescription meds
Herbal meds
VVE)eks P9stpartlJ~

25
19
26
25
26
26
26
26
26
26

Minimum

Maximum

18
105
58.00
1
1
1
1
0
0
4.1

35
205
70.00
4
3
3
2
3
1
7.5
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Mean

22.84
162.05
64.1538
1.96
1.81
1.62
1.38
.35

.04
5.150

Std. Deviation

4.356
32.399
3.12016
.841
.749
.571
.496
.689
.196
.9140

J

Lactating Group
25 of 26 milk samples were positive for chlorpyrifos (mean 1.10 ppb +/
.503 SO, when detectable the range was .32 to 2.29 ppb). 19 of 26 plasma
samples were positive for chlorpyrifos (mean .119 ppb +/- .106 S0, when
detectable the range was .019 to .296 ppb) and 10 of 26 saliva samples were
positive (mean .186 ppb +/- .299 S0, when detectable the range was .066 to
.972 ppb) (Table 3).
Eight of the subjects in the lactating group were positive for chlorpyrifos in
all three biological samples. Of these eight, the mean age was 29.37 years,
mean weight 188.83 pounds and mean height 67.4 inches. Seven of eight
subjects were Caucasian one was African American. The reported income was
$20,000 to $40,000 but most of them did not work. The majority of the subjects
was married and most reported one live birth. Only one smoked, two used
prescription drugs and none of them reported use of herbal medications. The
mean for the number of weeks postpartum at the time of data collection was 5.43
weeks.
Three Significant correlations were found in the lactation group (Table 4).
These correlations were between milk chlorpyrifos concentrations and number of
live births (r=. 517, p=. 007, N=26) (Figure 7); between plasma chlorpyrifos
concentrations and height (r=. 478, p=. 021, N=23) (Figure 8); and between milk
chlorpyrifos and plasma chlorpyrifos concentrations (r=. 444, p=. 030, N=24)
(Figure 9).
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Table 3. Statistics for biological samples in lactating group
Descriptive Statistics
N

Minimum

Maximum

Mean

Std. Deviation

Milk

26

NO

2.29

1.1015

.50321

Plasma

24

NO

.296

.11975

.106155

Saliva

26

NO

.972

.18623

.299087

Table 4. Spearman Rho Correlation matrix for lactating group
Spearman's Rho Correlations
Milk

Plasma

Height

Saliva

Live
births

Milk
Correlation
Coefficient
Sig. (2-tailed)
N

1.000

Correlation
Coefficient
Sig. (2-tailed)
N

.444*

1.000

.030
24

24

Correlation
Coefficient
Sig. (2-tailed)
N

- .037

.363

26

Plasma

Saliva

.857
26

.081
24

1.000
26

Height
.013
Correlation
Coefficient
.949
Sig. (2-tailed)
N
25
Live births
.517
Correlation
Coefficient
Sig. (2-tailed)
.007
26
N
* Correlation is significant at the .05 level (2 - tailed).
- Correlation is significant at the .01 level (2 - tailed)

.478*

.272

1.000

.021
23

.188
25

25

.097

- .342

- .198

1.000

.652
24

.088

.344
25

26
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Figure 7. Positive relationship of milk chlorpyrifos concentration
in parts per billion (ppb) and live births

74~4------------------------------------------------'

•

72

•
70

-

68

.c:

.2' 66
GI

::z::

64
62.

•

60.

•

58"
-.1

•
0.0

•
•

•

•

.1

.2

.3

.4

Plasma chlorpyrifos

Figure 8. Positive relationship of plasma chlorpyrifos concentration
in parts per billion (ppb) and height
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Figure 9. Positive relationship of milk and plasma chlorpyrifos
concentration in parts per billion (ppb)

Milk chlorpyrifos concentrations were not correlated with any other
demographic variables [age (r=. 167, p=. 424, N=25), weight (r=. 185, p=. 448,
N=19), race (r=-.311, p=. 121, N=26), income (r=. 105, p=. 625, N=24), work
(R=. 005, p=. 979, N=26), marital status (r=. 371 p=. 062, N=26), use of
t

prescription medications (r=-.057, p=. 783, N=26) or herbal medications (r=-.039,
p=. 853, N=25) or with the number of weeks postpartum (r=-.081, p=. 694,
N=26)]. Milk chlorpyrifos concentrations were not correlated with salivary
chlorpyrifos concentrations (r=-109, p=. 603, N=26).
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To test for differences in chlorpyrifos concentrations between the three
biological samples in the lactation group, the t-test for dependent samples was
used. A paired samples t-test was performed on milk/plasma, milk/saliva, and
plasma/saliva. Analysis showed that there was significantly higher milk
chlorpyrifos concentrations than either plasma (t=9.734, df=23, p=. 000) or
salivary concentrations (t=7.690, df=25 , p=. 000) (Table 5). The mean
chlorpyrifos milk concentration was 1.06 ppb +/- .502 SO compared to the means
for plasma chlorpyrifos .119 ppb +/- .106 SO and saliva chlorpyrifos .188 ppb +/
.299 SO (Table 6).

Table 5. Significance of difference in milk and plasma/saliva chlorpyrifos
Paired Samples Test
Paired Differences

Mean

Std.
Deviation

Std.
Error
Mean

95% Confidence Interval of
the Difference
Upper
Lower

t

df

Sig.
(2-tailed)

Milk.94108

.473645

.096682

.74108

1.14109

9.734

23

.000

Saliva

.91531

.606918

.119026

.67017

1.16045

7.690

23

.000

Saliva 
Plasma

.06871

.289686

.059132 '---- .05J,(;?

.19103

1.162

23

.257

Plasma

Milk-

-
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Table 6. Statistics for lactating group
Paired Samples Statistics
N

Pair 1 MilkPlasma

1.0608
.11975

24
24

Std.
Deviation
.50276
.106155

Pair 2

MilkSaliva

1.1015
.18623

26
26

.50321
.299087

.09869
.058656

Pair 3

Saliva 
Plasma

.18846
.11975

24
24

.310490
.106155

.063379
.021669

Mean

--

Std. Error
Mean
.10262
.021669

Non-lactating Group
In the non-lactating group, all but three of the plasma samples were
positive for chlorpyrifos with a mean of .149 ppb +/- .111 SO (range .020 to .395
ppb). Sixteen of the saliva samples were positive for chlorpyrifos with a mean of
.044 ppb +/- .061 SO (range .008 to .230 ppb) (Table 7). Fourteen of the subjects
in the non-lactating group were positive for chlorpyrifos in both plasma and
salivary samples. The mean age was 22.15 years, mean weight was 157.5
pounds (although five of the subjects did not report a weight) and mean height
was 63.78 inches. Thirteen of fourteen subjects were Caucasian and one was
African American. Most reported an income of $10,000 to $20,000 and most did
not work. Half the subjects were married and most reported two live births. Five
subjects smoked, four used prescription drugs and none of them reported use of
herbal medications. The mean for the number of weeks postpartum at the time of
data collection was 5.19 weeks.
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Table 7. Statistics for biological samples in non-lactating group
Descriptive Statistics
N

Minimum

Maximum

Mean

Std. Deviation

Plasma

24

.000

.395

.14992

.111530

Saliva

23

.000

.230

.04478

.061405

Fourteen of the subjects in the non-lactating group were positive for
chlorpyrifos in both plasma and salivary samples. The mean age was 22.15
years, mean weight was 157.5 pounds (although five of the subjects did not
report a weight) and mean height was 63.78 inches. Thirteen of fourteen subjects
were Caucasian and one was African American. Most reported an income of
$10,000 to $20,000 and most did not work. Half the subjects were married and
most reported two live births. Five subjects smoked, four used prescription drugs
and none of them reported use of herbal medications. The mean for the number
of weeks postpartum at the time of data collection was 5.19 weeks.
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Fourteen of the subjects in the non-lactating group were positive for
chlorpyrifos in both plasma and salivary samples. The mean age was 22.15
years, mean weight was 157.5 pounds (although five of the subjects did not
report a weight) and mean height was 63.78 inches. Thirteen of fourteen subjects
were Caucasian and one was African American. Most reported an income of
$10,000 to $20,000 and most did not work. Half the subjects were married and
most reported two live births. Five subjects smoked, four used prescription drugs
and none of them reported use of herbal medications. The mean for the number
of weeks postpartum at the time of data collection was 5.19 weeks.
Two significant correlations were found in the non-lactation group (Table
8). These correlations were between plasma chlorpyrifos concentrations and live
births (r=-. 433, p=. 035, N=24) (Figure 10) and between plasma chlorpyrifos
concentrations and work status (r=-.518, p=. 009, N=24) (Figure 11). The more
live births and the more the subject worked, the lower the plasma chlorpyrifos
concentrations.
To test for differences between the plasma and salivary concentrations in
the non-lactation group, the t-test for dependent samples was used. A paired
samples t-test was performed on plasma and saliva. Analysis showed that there
were significantly higher plasma chlorpyrifos concentrations than salivary in the
non-lactation group (t=-3.860, df=20, p=. 001) (Table 9). The mean chlorpyrifos
plasma concentration was .153 ppb +/- .110 SO compared to the mean
chlorpyrifos salivary concentration .043 ppb +/- .062 SD (Table 10).
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Table 8. Spearman Rho Correlation matrix for non-lactating group
Spearman's Rho Correlations
Work

Live births

Plasma

Work
Correlation Coefficient
Sig. (2 - tailed)
N

1.000

Correlation Coefficient
Sig. (2 - tailed)
N

.389*
.050
26

1.000

Correlation Coefficient
Sig. (2 - tailed)
N

- .518**
.009
2
4

- .433*
.0
35
24

26

Live births

26

Plasma
1.000
24

* Correlation is significant at the .05 level (2 - tailed).
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Figure 10. Negative relationship of plasma chlorpyrifos concentration in parts per
billion (ppb) and live births
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Figure 11. Negative relationship of plasma chlorpyrifos concentration
in parts per billion (ppb) and work status

Table 9. Significance of difference in plasma chlorpyrifos
Paired Samples Test
Paired Differences

Mean
Saliva 
Plasma

- .10962

Std.
Deviation
.130132

Std.
Error
Mean
.028397

95% Confidence Interval
of the Difference
Upper
Lower
- .16885

89

L

- .05038

t

df

- 3.860

21

Sig.
(2-tailed)

·()()t

IIIIIIII

Table 10. Statistics for non-lactating group
Paired Samples Statistics
Mean

Pair 1

Saliva 
Plasma

N

.04390
.15352

Std.
Deviation
21
21

Std. Error
Mean

.062022
.110290

.013534
.024067

To test for differences in plasma and salivary chlorpyrifos concentrations
between the lactating and non-lactating group, a t-test for comparison of means
for independent samples was used. The mean plasma chlorpyrifos concentration
in the lactation group was .119 ppb +/- .106 SO compared to .149 ppb +/- .111
SO in the non-lactation group. However, the mean salivary chlorpyrifos
concentration in the lactation group was .186 ppb +/- .299 SD compared to .044
ppb +/- .061 SO in the non-lactation group (Table 11). There was not a significant
difference in plasma chlorpyrifos concentrations between the two groups.
However, in the salivary chlorpyrifos concentrations, the Levene test did provide
sufficient evidence of group difference (F=26. 74, p=. 000) so the equal variances
not assumed test was used (t=2.356, df=27.36, p=. 026). There appears to be a
significant difference in salivary chlorpyrifos concentrations between the two
groups and based on the mean, the salivary concentrations in the lactation group
are significantly higher than in the non-lactation group (Table 12).
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co
.000

.A52

Sig.

2.356

2.224

- .960

- .960

t
46

Saliva

Plasma

FEED 3
breast
bottle
breast
QQttlEt_

0.31

.342

.342

27·369 ______ .026

47

45.888

df

Sig.
(2 taUed)

N
24
24
26
21

Group Statistics

Table 12. Significance of difference in salivary chlorpyrifos

Equal variances
___ ___riot a~sume_d~___
'----

26.778

Equal variances
not assumed
Equal variances
assumed

Saliva

.035

Plasma Equal variances
assumed

F

Levene's Test
for Equality
of Variances

Independent Samples Test

Table 11. Statistics for lactating and non-lactating groups

-

Mean
.11975
.14992
.18623
.04478

'--__ ~~l~ ~_.

.14145

- .03017

- .03017

Mean
Difference

.013526

-.093436

- .093432

Lower

,-0~'1405

.106155
.111530
.299087

Std. Deviation

_

.021669
.022766
.058656
.012804

Std. Error Mean

.~e4.55~ __

.269371

.033102

.033098

Upper

the Difference

95% Confidence Interval of

____.0§0Q.3?_ __ ___ .Ql§34..0

.063588

.031430

.031430

Std. Error
Difference

t-test for Equality of Means

1
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CHAPTER FIVE
DISCUSSION
This study was conducted to determine if an organophosphate insecticide,
chlorpyrifos, was present in the breast milk, plasma, and saliva of lactating
mothers in comparison to non-lactating mothers. Various pesticides, such as
chlordane, DDT, dieldren and heptachlor, have already been documented in
human breast milk. Because organophosphates, along with synthetic pyrethroids,
comprise 700/0 of the insecticide market share, it was possible that chlorpyrifos
may also be found in women's breast milk. The results of this study have shown
that chlorpyrifos is present in breast milk, plasma, and saliva of lactating and
non-lactating mothers in measurable concentrations. A discussion of the findings
is presented in this chapter, followed by the implications for nursing and
recommendations for future studies.
The purpose of this study was to determine the concentration range of
chlorpyrifos in human breast milk, plasma and saliva from lactating mothers
compared to non-lactating mothers. The samples were chosen from a previously
funded research study on stress and lactation. There were a total of 26
participants in two groups: one from women who were exclusively lactating and
the other from formula feeders. Overall, for the lactation group, milk chlorpyrifos
concentrations were significantly higher than plasma or saliva. Plasma
chlorpyrifos concentrations were significantly higher than saliva in the non
lactation group. Comparing the two groups, saliva chlorpyrifos was significantly
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higher in the lactation group_
Traditionally, environmental epidemiologists examine the association
between exposures to pesticides and adverse health outcomes through risk
assessment. This process involves a quantitative estimation of the environmental
exposure and the subsequent entry into the human body_ In general, most
pesticide studies collect historical information regarding pesticide use and
exposure via questionnaires or interviews. Since this study involved the use of
secondary analysis of biological specimens from a previous study, this
researcher was not able to correlate pesticide exposure with the pesticide
concentrations found in the three specimens. Even though chlorpyrifos exposure
can be variable and can occur through multiple routes, pattern use of chlorpyrifos
applications or other types of information could have been an important
supplement to biological monitoring. For instance, an acute exposure might
explain the difference in chlorpyrifos concentrations among the different
specimens in a particular individual. Also, information such as WOrkplace
environment or pesticide use during pregnancy would have been helpful in
quantifying higher chlorpyrifos concentrations. Since over 400/0 of Tennessee's
total land area is farmland, with cropland accounting for more than 630/0
(Tennessee Agriculture, 2004), additional information such as proximity to
agricultural fields would have also been important information.
This study used quantitative analytical methodology, such as biological
monitoring, to determine whether chlorpyrifos was in breast milk, plasma, and
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saliva and in measurable concentrations. Each biological sample was analyzed
for chlorpyrifos using an ELISA that measured concentrations in parts per billion.
The results validated that chlorpyrifos is present not only in breast milk but also in
plasma and saliva as well. This is the first known publicized study of chlorpyrifos
analysis in human breast milk in the United States, and it is the first publicized
study to use an ELISA specific to chlorpyrifos for the analysis of human biological
specimens.
Virtually all laboratory studies utilize gas chromatography to assess low
levels of environmental contaminants such as pesticides. Not only is this type of
analysis extremely expensive but it also requires the use of skilled analysts.
Therefore, there is a growing demand for reliable, cost effective methods for
determining pesticide exposure by more efficient techniques. Following an
extensive search, an immunoassay specific to chlorpyrifos was discovered for
use in water, soil, cereal, and fruit. Even though this particular assay had never
been performed with human body fluids, the assay performed appropriately when
the samples were spiked with varying amounts of chlorpyrifos concentrations.
The breast milk, plasma and saliva concentrations followed an appropriate linear
curve based on the amount of chlorpyrifos spiked in the sample.
Pre-analytic activities, such as specimen collection, transport, specimen
handling and storage, and identification of patient information are important
measures. Because this study used biological samples taken from a previous
research study, this researcher was unable to validate those methods employed
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by the mother in collection of the breast milk or saliva samples. In addition, this
researcher was unable to validate the manipulation or storage of the samples
upon arrival to the laboratory.
There are also quality assurance procedures to aid in the reproducibility of
the assay guide. This includes accuracy and precision to ensure the validity of
the assay results. Standards and controls were incorporated into every assay to
ensure appropriate testing performance. In addition, several sample assays were
run to determine the ability of the assay to consistently reproduce the same result
from the same specimen. The interassay coefficient of variation was 1a.560/0 in
the breast milk specimens sampled.
There were several issues with the assay that were out of this
researcher's control. For instance, the Chlorpyrifos RaPID Assay, states on the
package insert that the test is unable to differentiate between chlorpyrifos and
other related compounds that have the same phosphate moiety; however,
according to the limit of quantification, the test is at least

ax more sensitive to

chlorpyrifos than any of the other compounds. In addition, the limit of detection
(LOD) for this particular assay was 0.1 ppb with a linear range of 0.22 to 3.0 ppb.
Therefore, it is impossible to determine if those samples with non-detectable
concentrations were actually zero or simply below limits of detection of the assay.
Unfortunately, it is not possible to compare the results of this assay to
previous studies because all other reported chlorpyrifos studies used gas
chromatography as their instrument of analysis. Some researchers analyzed the
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parent compound, some chlorpyrifos oxon and other researchers analyzed
chlorpyrifos metabolites. For example, in the study from India, the researchers
describe the use of gas chromatography as their instrument for organophosphate
analysis, but they did not report how chlorpyrifos was analyzed. However, as in
this study, the researchers did find 12 out of 12 breast milk samples positive for
chlorpyrifos with a mean of .230 ppm +/- 0.024 SO (range .085 to 0.355 ppm). It
is important to note the differing concentrations between the studies. Sanghi et
ai, reported chlorpyrifos concentrations in the parts per million as compared to
this and other studies of chlorpyrifos concentrations in the parts per billion.
Because chlorpyrifos is used extensively in agriculture, particularly wheat and
rice crops, this might explain the discrepancy in high concentration levels
(Sanghi, Pillai, Jayalekshmi & Nair, 2003).

Lactating Group
In the lactation group, there were 26 samples each of breast milk,
plasma and saliva. In this group, the findings were that 25 out of 26 (96%) breast
milk samples were positive for chlorpyrifos, 19 out of 26 (73%) plasma samples
were positive, and 10 out of 26 (380/0) saliva samples were positive for
chlorpyrifos. The findings also show that there was significantly higher
chlorpyrifos concentrations in milk than either in plasma or salivary
concentrations. In addition, 8 out of 26 subjects (30%) were positive in all three
biological samples.
Many chemicals can be transferred from the blood and/or from the body
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fat stores into the breast milk of a lactating mother. Lipophilic chemicals, such as
chlorpyrifos, can accumulate in maternal fat reserves and then be mobilized via
lactation through the process of depuration. This pathway, known as the
lactational transfer pathway, depends on a number of factors such as the
chemical itself, the mother and the milk.
The penetration of a chemical across the cell membrane is dependent
upon several properties of the chemical. These include among others, degree of
ionization, molecular size, hydrophobicity, and binding to maternal plasma
proteins. Chlorpyrifos is non-ionized and since breast milk is more acidic (pH of
6.5 to 7.2) than plasma (7.5), chlorpyrifos concentrations should be higher in the
milk since chlorpyrifos passes readily through the cell membrane. Diffusion into
the cell membrane is also dependent upon the molecular size of the chemical in
that the smaller the molecular weight, the easier it transfers into the lipid barrier
of the cell. The mammary epithelium membrane is semi-permeable in that it
allows chemicals of low molecular weight passage through the cell membrane.
Chlorpyrifos has a molecular weight of 350.6 and thus is able to penetrate
through the cell membrane.
The most significant property associated with chlorpyrifos is its
hydrophobicity, better known as its lipid solubility. Chemicals are able to partition
into milk according to their lipophilicity or octanol: water partition coefficient.
Chlorpyrifos has a high lipid solubility coefficient of 4.7 to 5.3 rendering it capable
of concentrating in the milk fat and thus producing higher levels in the milk than
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in the plasma. Finally, those chemicals that become bound to proteins in the
blood become trapped and unavailable for lactational transfer. Both plasma and
milk contain proteins but none of the major proteins in breast milk tend to bind
chemicals. Therefore, lipid soluble chemicals, like chlorpyrifos, tend to be in
continual exchange with the maternal circulation and the milk.
Several maternal factors influence the risk of chemical concentration in the
breast milk: the route of exposure, maternal age and weight, number of births,
and duration of lactation. Because chlorpyrifos exposure can occur through all
the various exposure scenarios (oral, dermal, inhalation, and take-home
pathways), the assumption was made that all women are exposed to and
accumulate this chemical over a lifetime. Based on this assumption, it makes
sense that the amount of the chemical concentration would increase with age.
However, there was no correlation between maternal age and chlorpyrifos
concentration in any of the three samples. This finding might be explained in part
because of the young age in this population. The average age was 28.28 years,
which suggests that these mothers might not have had as much chlorpyrifos
exposure in their lifespan.
Weight was not correlated with chlorpyrifos concentrations either.
Unfortunately there are virtually no studies regarding the absorption, metabolism,
and excretion of organophosphate pesticides in pregnant women. For instance,
does post pregnancy weight loss impact the amount of chemical excretion?
Since body fat contributes to the concentration of chemicals in the breast milk, it
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could be argued that any abrupt weight loss could create a physiological
excretion response, not just to the breast milk but to all other secretory pathways
as well (Le. hair, tears, sweat, fingernails, and saliva). Another possibility is that
with sudden weight loss, the chemicals can be released back into circulation and
thus into the fat of the mammary gland. Since seven of the subjects did not report
a weight and another six subjects reported a weight greater than 180 pounds, it
is possible that sudden weight loss had not occurred by the time of data
collection.
There was a significant positive correlation between plasma chlorpyrifos
concentrations and height, despite the finding that there was not a correlation
between plasma or milk and body mass index. Because seven subjects in each
of the two groups did not report their weight, an explanation is that there might
have been a correlation had that information been included. Also, since the
subjects reported their own height and weight and the average weeks
postpartum at the time of data collection was approximately five weeks, those
weight measurements could have been taken following discharge from the
hospital (four to five weeks earlier) or at their four week postpartum check (one
week earlier), suggesting that their current weight might not have been truly
reflected at the time of milk collection.
Another maternal factor that can influence the chemical concentration in
breast milk is parity. It has been established that lipophilic chemicals are stored
in body fat over time and then mobilized into the milk during lactation. Other
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chemical studies have shown that the concentration decreases with the number
of children that are breast-fed. There was a significant positive correlation
between milk chlorpyrfios concentrations and the number of live births. Because
this study was dependent upon the demographic information attained from the
original study, this researcher is not sure if the mothers were including their
recently born infant as a live birth since the average number of live births was
1.8. In addition, there was not any information regarding feeding type with any
previous children so it is impossible to know whether this particular infant was the
first to be breast-fed or whether this factor might influence the results of this
study.
Factors that influence chlorpyrifos in breast milk include milk composition
and milk to plasma ratio. The composition of milk changes according to the
gestational age of the infant. Just as chlorpyrifos concentration decreases with
the number of nursed children, so does the amount of chlorpyrifos over the
course of lactation. As a mother breast-feeds, the concentrations of chemicals in
breast milk decline over the weeks and months of lactation.
Changes in the fat content of breast milk can occur during a feeding, from
feeding to feeding, and over time. Since lipophilic chemicals pass into the milk,
the fat concentration is probably the most crucial and variable of all factors.
Lactogenesis II begins about 40 hours after birth and lasts approximately five
days. The fat content during this stage is approximately 2.9%. The next stage of
milk development is the transitional milk and it generally lasts from day six to day
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ten of lactation. During this stage, immunoglobulin and protein content starts to
fall while fat begins to rise so that by full lactation (galactopoiesis), the fat content
is approximately 4%. In addition, hind milk can have an overall higher fat
concentration (4 to 6%) compared to foremilk (1 to 2%).
Studies have shown that lactation is a functional excretion pathway for
lipophilic chemicals and by four to six weeks, and in this study the measurable
concentrations of chlorpyrifos has diminished. The average number of weeks
postpartum at the time of data collection was approximately five weeks, and
there did not appear to be a correlation between milk chlorpyrifos values and the
number of weeks of lactation. The subjects were carefully scrutinized by the
researchers as to their exclusivity to ensure that mothers were strictly bottle
feeding or breast feeding and not supplementing with other sources of nutrition.
In addition, lactating mothers were given an information sheet instructing them to
collect their milk from the breast when finished nursing either by hand expression
or breast pumping. The samples were to be collected in the morning between

7:00 a.m. and 12:00 noon and then immediately placed in the refrigerator.
However, since the information packets were sent out well in advance of data
collection, it is impossible to know not only what time of day the milk samples
were taken but also during what part of the feeding cycle milk samples were
taken. In addition the variation in sampling time (Le. three to four weeks
postpartum compared to five to seven weeks postpartum) could have played a
significant role in the amount of milk chlorpyrifos concentrations.

101

~

.
The milk to plasma (M/P) ratio is 'an estimation of a chemical
concentration in milk compared to its concentration in maternal plasma.
Pharmacologists often use this ratio to estimate the amount of drug delivered via
breast milk to the nursing infant. Those chemicals with a high M/P ratio are
thought to have higher concentrations in the milk than in plasma, and those with
lower M/P ratios are thought to be lower in milk and higher in plasma. Most
chemical profiles that exhibit higher M/P ratios are very fat-soluble, have weak
bases and small ionization potential. Since chlorpyrifos has the appropriate
characteristics associated with a higher M/P ratio, this would explain the positive
correlation between milk and plasma chlorpyrifos concentrations as well as the
statistically higher milk chlorpyrifos values compared to plasma.

Non-lactating Group
There were 26 samples each of plasma and saliva in the non-lactation
group. In this group, the findings show that 23 out of 26 (880/0) plasma samples
were positive for chlorpyrifos and 16 out of 26 (610/0) saliva samples were
positive. In addition, 14 out of 26 subjects were positive for both. The findings
also showed that there were significantly higher plasma chlorpyrifos
concentrations in this group.
During pregnancy, many physiological changes occur in the mother as a
result of the rapid growth of the fetus and reproductive organs. These changes
directly influence the toxicokinetics (absorption, distribution, metabolism, and
elimination) of lipophilic chemicals. For instance, cardiac output increases by
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50%, resulting in an increased blood volume followed by increased chemical

I

distribution. In addition, the amount of chemicals bound to plasma proteins also
increases considerably. Therefore, fat body stores would be expected to mobilize
with subsequent release into the circulatory system. This would explain the high
plasma chlorpyrifos concentrations. It is theorized that the chemical in the
adipose storage depot is in relative equilibrium with the concentration in the
blood or plasma so that as the chemical is released into the blood, it is also being
eliminated from the blood to maintain the equilibrium. According to Rozman and
Klaassen (2001),
The compartment where a chemical is concentrated can be thought of as
a storage depot. Toxicants in these depots are always in equilibrium
with the free fraction in plasma. As a chemical is biotransformed or
excreted from the body, more is released from the storage site. As a
result, the biological half-life of stored compounds can be very long.
Because the pharmacokinetics for plasma and saliva are comparable to
each other, it would seem logical that chlorpyrifos would behave similarly in both
compartments. However, before any chemical circulating in the plasma can be
excreted into the salivary duct, it must contain certain physicochemical properties
that allow it passage into the lipophilic layer of the salivary epithelial cell
membrane, such as lipophilicity and molecular size. Those chemicals with high
lipid: water partition coefficients, and low molecular weights can influence
passive diffusion from the plasma to the saliva. This is accomplished by
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permeating cell membranes through the aqueous pores and therefore expending
no energy (Rozman & Klaassen, 2001). In a study of rats exposed to diazinon
(another organophosphate with a similar chemical structure as chlorpyrifos),
concentrations in saliva were consistently lower than those in arterial plasma.
The authors suggest that this difference is most likely due to protein binding of
diazinon in the plasma (Fenske, Lu, & Showlund-Irish, 2005). Since chlorpyrifos
and diazinon are so chemically similar, this could explain the resultant
concentrations in the two compartments.
There were two significant correlations in the non-lactation group between
plasma chlorpyrifos concentrations, live births and work status. The more live
births reported the lower the plasma concentrations and those that worked part
time had lower concentrations as well. It could be argued that fat stores were
mobilized into the circulatory system and potentially excreted (kidneys, saliva,
etc.) with each subsequent pregnancy and birth. In addition, those that worked
part-time to full-time spent less time at home with subsequently less chlorpyrifos
exposure. Again, since the subjects were younger in age, it is possible that their
work environments were safer than home in that some may still have chlorpyrifos
containing products in their garages or under their sinks.
Analysis between the lactation group and the non-lactation group revealed
significantly higher salivary chlorpyrifos concentrations in the lactation group.
Since the lactation group had significantly higher milk chlorpyrifos concentrations
as well, it makes sense that both of these excretion pathways have been
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saturated with chlorpyrifos. In addition, the fact that chlorpyrifos is so lipophilic
and the fat in milk is higher than in saliva, would explain why the milk would
contain higher concentrations than the saliva.
Nursing Implications
Based upon the findings of this study, it can be concluded that chlorpyrifos
is present in breast milk in measurable amounts. If chlorpyrifos is present, then
what other environmental chemicals are also present in breast milk? This begs
the question, "What are these chemicals doing to our precious children?" Those
questions can only be answered through future studies.
The nursing profession has a unique opportunity to take the lead in
addressing the health issues associated with environmental contaminants. All
nurses need to be more educated with toxicology concepts and public health
issues as this affects nurses at every level. Nurses need to become more
involved in research endeavors so that we are armed with scientific evidence of
health effects of chemical contamination and exposure. The results of this study
alone could be a pivotal beginning in spurring bigger laboratories to test not only
this chemical but also other chemicals like it.
Breast is always best; however, mothers need to be aware of the
associated dangers of this and other pesticides. Not only pregnant women and
nursing mothers but also women everywhere need to be better informed of the
potential effects of pesticide exposure throughout the lifespan. Of course, the first
and most important concern is the health of our children and the disastrous
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effects these chemicals could be having on their developing brains. However,
another concern, which this paper did not address, is women's health issues,
such as breast cancer, autoimmune diseases, and osteoporosis. Is there an
increased propensity for women to develop breast cancer as a result of a lifetime
of toxic poisons stored in their breast tissue? What about the women who do not
breast-feed? Are these toxins getting excreted in other ways or are they stored
continuously in the adipose tissue? Education is paramount, and unfortunately
we can no longer leave the education role in the hands of the Environmental
Protection Agency or in the hands of the professional exterminator. Now is the
time to better educate our communities on the dangers of chlorpyrifos, diazinon
or any other toxic chemical. We cannot wait until there is sufficient evidence to
ban the chemical from use because as we now know, that is too late as it has
already saturated itself into the soil, the water, and our ecological system. In
summary, nursing can protect the health and well being of women, mothers and
their infants by generating new knowledge via scientific findings, communicating
the associated health implications and implementing this knowledge into nursing
practice.

Future Studies
The future of a healthy tomorrow depends on the science of yesterday.
We are walking petri dishes full of scientific evidence of environmental
exposures. All one has to do is test. We cannot rely on animal testing to
determine the biopartition of any chemical in the environment or in the body. All
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of these chemicals need to be tested on animals, retested on animals, and then
tested again on animals until the scientific community is absolutely confident that
a chemical does not pose a threat to our health. Even this study could be
validated using gas chromatography so that more chemical assays could be
developed to allow for easier and cost effective monitoring.
Participation in a comprehensive breast milk-monitoring program is key to
an informed public. This would allow for the development of standardized
protocols for specimen collection and analysis worldwide. Dr. LaKind (2001) and
associates have agreed unanimously to develop such a program so that women
from various socioeconomic backgrounds and geographic locations can be
tested under similar conditions. This testing would provide scientifically based
information to breast-feeding women on the risks of various chemicals.
It is imperative that studies be done on our children. In a study by Perea
(2003), chlorpyrifos concentrations were strongly associated with decreased birth
weight and body length in babies of African-American women living in New York
City. Additional studies, not just those involving chlorpyrifos, need to be
prospectively performed to assess cognitive motor deficits, IQ and developmental
delays.

Summary
There is mounting evidence of pesticide contamination in the breast milk
of lactating women. This study has contributed to this knowledge by documenting
chlorpyrifos concentrations in breast milk, plasma and saliva of lactating and non-
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lactating women. Bio monitoring of human breast milk provides an easy way to
determine the body burden of lipophilic chemicals such as chlorpyrifos. Our
children's health depends on it.

108

...

w

CI)

U

z

W

w
c::::
W

LL

c::::

0')

"'l'-"

o

II

REFERENCES
Abdollahi, M., Balai-Mood, M., Akhgari, M., Jannat, B., Kebriaeezadeh, A., &
Nikfar, S. (1996). A survey of cholinesterase activity in healthy and
organophosphate exposed populations. Iranian Journal of Medical

Science, 21 (1 & 2), 68-73.
Adgate, J. L., Barr, D. B., Clayton, C. A., Eberly, L. E., Freeman, N. C.,
Lioy, P. J. (2001). Measurement of children's exposure to pesticides:
An analysis of urinary metabolite levels in a probability-based sample.

Environmental Health Perspectives, 109,583-590.
Andersen, H. R., Nielsen, J. B. & Grandjean, P. (2000). Toxicologic evidence
of developmental neurotoxicity of environmental chemicals. Toxicology,
144, 121-127.
Anderson, P. O. (1991). Therapy review: Drug use during breast feeding.

Clinical Pharmacokinetics, 10, 594-624.
Barr, D. B., Wang, R. Y., & Needham, L. L. (2005). Biologic monitoring of
exposure to environmental chemicals throughout the life stages:
Requirements and issues for consideration for the National children's
Study. Environmental Health Perspectives, 113 (8), 1083-1091.
Barr, D. B., Allen, R., Olsson, A. 0., Bravo, R., Caltabiano, L.M.,
Montesano, M. A., Nguyen, J. V., Walker, R. D., Weeraskekera, G.,
Udunka, S. 0., Schober, S. E., & Needham, L. L. (2004).
Concentrations of specific metabolites of organophosphorus
pesticides in U. S. population. Environmental Health Perspectives,
110

I.

112, 186-200.
Barr, D. B. & Needham, L. L. (2002). Analytical methods for biological
monitoring of exposure to pesticides: A review. Journal of

Chromatography B, 778 (1-2),5-29.
Barrett, J. R. (2001). Chemicals in breast milk: Little data to date.

Environmental Health Perspectives, 109 (1), A38-A39.
Barron, M. G., Plakas, S. M. & Wilga, P. C. (1991). Chlorpyrifos
pharmacokinetics and metabolism following intravascular and
dietary administration in channel catfish. Toxicology and Applied

Pharmacology, 108 (3), 474-482.
Bearer, C. (1995). How are children different than adults? Environmental

Health Perspectives, 103 (suppI6); 7-12.
Benbrook, C. M. (2000). Pesticide residues in Forida fresh market tomatoes.
Counsulting Service Ecologic, Inc.
Berkowitz, G. S., Wetmur, J. G., Birman-Deych, E., Obel, J., Lapinski, R. HI,
Godbold, J. H., Holzman, I. R., & Wolff, M. S. (2004). In utero pesticide
exposure, maternal paraoxonase activity, and head circumference.

Environmental Health Perspectives, 112, 388-391.
Berkowitz, G. S., Obel, J., Deych, E., Lapinski, R., Godbold, J., Liu Z., Landrigan,
P. J. & Wolff, M. S. (2003). Exposure to indoor pesticides during
pregnancy in a multiethnic urban cohort. Environmental Health

Perspectives, 111(1),79-84.
Berlin, C. M. & Kacew, S. (1997). Environmental chemicals in human milk:
111

.
In S. Kacew & G. H. Lambert (Eds.), Environmental Toxicology in

Human Development. Washington D. C.: Taylor and Francis.
Berlin, C. M. (1986). Drug excretion into human milk. In M. Hamosh & A. S.
Goldman (Eds.), Human Lactation 2: Maternal and Environmental Factors.
New York: Plenum Press.
Black, R. F. (1996). Transmission of HIV-1 in the breast-feeding process. Journal

Of the American Dietetic Association, 96, 267-274.
Blondell, J. (1999). Review of chlorpyrifos methyl incident reports. U.S.
EPA Memorandum.
Boone, J. 5., Tyler, , J. W., & Chambers, J. E. (2001). Transferable residues from
dog fur and plasma cholinesterase inhibition in dogs treated with a flea
control dip containing chlorpyrifos. Environmental Health Perspectives,
109 (11), 1109-1114.
Bradman, A. (2003). Measurement of pesticides and other toxicants in amniotic
fluid as a potential biomarker of prenatal exposure: A validation study.

Environmental Health Perspectives, 111, 1779-1782.
Brack, M. & Rothe, H. (1982). Organophosphate poisoning in marmosets.

Laboratory Animals, 16, 186-188.
Brillant, L. B., Wilcox, K., Van Amburg, G., Eyster, J., Bloomer, A. W., Humphrey,
H., & Price, H. (1978). Breast-milk monitoring to measure Michigan's
contamination with polybrominated biphenyls. Lancet, 2 (8091), 643-646.
Byczkowski, J. Z., Kacew, 5., Miller, R. K., Pelkonen, 0., & Saunders, N. (2001).
Exploration of perinatal pharmacokinetic issues. Risk Assessment Forum.
112

....

r
Office of Research and Development. Environmental Protection Agency.
Washington D. C.: Versar, Inc.
Byrne, S. L., Shurdut, B. A., & Saunders, D. G. (1998). Potential chlorpyrifos
exposure to residents following standard crack and crevice treatment.

Environmental Health Perspectives, 106 (11),725-731.
Carson, R. (1962). Silent spring. Cambridge: Riverside Press.
Castorina, R., Bradman, A., McKone, T. E., Barr, D. B., Harnly, M. E.,

& Eskenazi, B. (2003). Cumulative organophosphate pesticide exposure
and risk assessment among pregnant women living in an agricultural
community: A case study from the CHAMACOS cohort. Environmental

Health Perspectives, 111, 1640-1648.
Chaffrey, C. E., Dobozy, V. A., & Hussey, D. J. (2000). Pesticide regulation. In
B. Ballantyne, T. Marrs, & T. Syversen (Eds.), General and Applied

Toxicology (2nd Ed.) New York: Grove's Dictionaries, Inc.
Chambers, H. W. (1992). Organophosphorus compounds: An overview. In

J. E. Chambers & P. E. Levi (Eds.), Organophosphates: Chemistry,
Fate and Effects (pp. 3-17). New York: Academic Press.
Chanda, S. M., Harp, P., Liu, J., & Pope, C. N. (1995). Comparative
developmental and maternal neurotoxicity following acute gestational
exposure to chlorpyrifos in rats. Journal of Toxicology and Environmental

Health, 189-202.
Chanda, S. M. & Pope, C. N. Neurochemical and neurobehavioral effects of
repeated gestational exposure to chlorpyrifos in maternal and developing
113

•
rats. Pharmacological and Biochemical Behaviors, 53, 771-776.
Chang, M. J., Lin, C. Y., Lo, L. W., & Lin, R. S. (1996). Biological monitoring
of exposure to chlorpyrifos by high performance liquid chromatography.

Bulletins of Environmental and Contaminated Toxicology, 56, 367-382.
Clewell, R. A. & Gearhart, J. M. (2002). Pharmacokinetics of toxic chemicals
in breast milk: Use of PBPK models to predict infant exposure.

Environmental Health Perspectives, 110, A333-A337.
Costa, L. G., Cole, T. B., & Furlong, C. E. (2003). Polymorphisms of
paraoxonase (PONI) and their significance in clinical toxicology of
organophosphates. Journal of Toxicological and Clinical Toxicology,
41 (1), 37-45.
Cox, C. (1994). Chlorpyrifos fact sheet, part 1. Journal of Pesticide Reform,
15 (1),1-13.
Cox, C. (1995). Chorpyrifos fact sheet, part 2. Journal of Pesticide Reform,
14 (4), 1-11.
Currie, K. L., Mcdonald, E. C., Chung, L. T. (1990). Concentrations of diazinon,
chlorpyrifos, and bendiocarb after application in offices. American

Industrial Hygiene Association, 51 (1),23-27.
Davis, D. L. & Ahmed, A. K. (1998). Exposures from indoor spraying of
chlorpyrifos pose greater health risk to children than currently estimated.

Environmental Health Perspectives, 106 (6), online.
De Peyster, A., Willis, W.O., Molgaard, C. A., MacKendrick, T. M., & Walker,
C. (1993). Cholinesterase and self-reported pesticide exposure among
114

.....

pregnant women. Archives of Environmental Health, 48, 348-352.
Diggle, G. E. (2000). Overview of regulatory agencies. In B. Ballantyne, T. Marrs,
T. Syversen (Eds.), General and Applied Toxicology (2 nd Ed.) (pp.

).

New York: Grove's Dictionaries, Inc.
Dixon, J. K. & Dixon, J. P. (2002). An integrative model for environmental health
research. Advanced Nursing Science, 24(3),43-57.
Dorman, D. C., Allen, S. L., Byczkowski, J. Z., Claudio, L., Fisher, J. E.,
Fisher, J. W., Harry, G. J., Li, A. A., Makris, S. L., Padilla, S., Sultatos,
L. G., & Mileson, B. E. (2001). Methods to identify and characterize
developmental neurotoxicity for human health risk assessment III:
Pharmacokinetic and pharmacodynamic considerations. Environmental

Health Perspectives, 109 (Suppl 1), 101-111.
Ecobichon, D. J. (1997). Anticholinesterase insecticides. In H. E. Lowndes &
K. R. Renhl (Eds.), Comprehensive Toxicology (pp. 447-456). New York:
Elsevier Ltd.
Ecobichon, D. J. (2001). Toxic effects of pesticides. In C. D. Klaassen (Ed.),

Casarett and Doull's Toxicology: The Basic Science of Poisons
(pp. 763-810). New York: McGraw-Hili.
Eisenreich, S. J., Booney, B. B., & Thornton, J. D. (1981). Airborne organic
contaminants in the Great Lakes Ecosystem. Environmental Science of

Technology, 15,30-38.
Eliot, L. (2000). What's going on in there: How the brain and mind develop

in the first five years of life. New York: Bantam Books.
115

I..

.
Environmental Protection Agency (2001). Exploration of perinatal
pharmacokinetic issues. Contract No. 6-C-99-238. Task Order No. 13.
Washington D.C.
Environmental Protection Agency (1997). Review of chlorpyrifos poisoning data.
Office of Prevention, Pesticides and Toxic Substances. Washington D. C.
Environmental Protection Agency (1997). Questions and answers,
chlorpyrifos. Office of Prevention, Pesticides and Toxic Substances.
Washington D. C.
Environmental Protection Agency (1992). National study of chemical residues in
fish. Office of Water. Washington D. C.
Environmental Protection Agency (1988). Integrated risk information system data
base. Washington, D. C.
Environmental Working Group (1998). Overexposed: Organophosphate
insecticides in children's food. Washington D. C.
Environmental Working Group (2004). Mothers' Milk: Record levels of toxic fire
retardants found in American mothers; breast milk. Washington D. C.
Eskenazi, B., Bradman, A., & Castorina, R. (1999). Exposures of children to
organophosphate pesticides and their potential adverse health effects.

Environmental Health Perspectives, 107 (supp. 3),
Faustman, E. M. & Omenn, G. S. (2001). Risk Assessment. In C. D. Klaassen
(Ed.), Casarett and Doull's Toxicology: The Basic Science of Poisons (pp.
83-104). New York: McGraw-HilI.
Fenske, R. A., Bradman, A., Whyatt, R. M., Wolff, M. S., & Barr, D. B. (2005).
116

....

Lessons learned for the assessment of children's pesticide exposure:
Critical sampling and analytical issues for future studies. Environmental
Health Perspectives, 113 (10), 1455-1462.
Fenske, R. A., Lu, C. Barr, D., & Needham, L. (2002). Children's exposure to
chlorpyrifos and parathion in an agricultural community in central
Washington State. Environmental Health Perspectives, 110, 549-553.
Fenske, R. A., Black, K. G., Elkner, K. P., Lee, C. L., Methner, M. M., & Soto, R.
(1990) Potential exposure and health risks of infants following indoor
residential pesticide applications. American Journal of Public Health, 80
(6), 689-693. Food Quality Protection Act of 1996 (1996). Public Law
104-170.
Fry, S. T., Donnelly, G., Burgess, A. W., Doswell, W. M., Kelly, L. S., Moody, L.
E., Peters, D. A., Ventura, M. R., & Birnbach, N. (2003). Persistent
organochlorine compounds in human milk. Nurses Leadership Council.
Washington DC.
Furst, P., Kruger, C., meemke, H. A. & Groebel, W. (1989). PCDD and PCDF
levels in human milk: Dependence on the period of lactation.
Chemosphere, 18,439-444.
Giroux, D., Lapointe, G, & Baril, M. (1992). Toxicological index and the
presence in the workplace of chemical hazards for workers who breast
feed infants. American Industrial Hygiene Association Journal, 53,
471-474.
Gramatica, P. (2004). Evaluation of different statistical approaches to the
117

...

.
validation of quantitative structure-activity relationships.
http://ecb.jrc.itlQSARlunderQSARs/documents/publicaccess.
Groer, M. W., Humenick, S., & Wilson, J. (2002). Selection of subjects for human
milk surveillance and research studies. Joumal of Toxicology and

Environmental Health, 65, 1853-1865.
Gupta, R. X. & Sastry, B. V. (2000). Toxicology of the placenta. In B. Ballantyne,
T. C. Marrs, & T. Syversoen (Eds.), General and Applied Toxicology
(2nd Ed.) (p. 1233-1265). New York: Grove's Dictionaries, Inc.
Gurunathan, S., Robson, M., Freeman, N., Buckley, B., Roy, A., Meyer, R.,
Bukowski, J., & Lioy, P. J. (1998). Accumulation of chlorpyrifos on
residential surfaces and toys accessible to children. Environmental

Health Perspectives, 106 (1),9-16.
Harvey, R. A. & Champe, P. C. (1992). Lippincott's Illustrated Reviews:

Pharmacology. Philadelphia: J. B. Lippincott.
He, F. (1999). Biological monitoring of exposures to pesticides: Current
issues. Toxicology Letters, 109, 277-283.
Hill, R. H., Head, S. L., Baker, S., Gregg, M., Shealy, D. B., Bailey, S. L.,
Williams, C. C., Sampson, E. J., & Needham, L. L. (1999). Pesticide
residues in urine of adults living in the United States: Reference
range concentrations. Environmental Research, 71,99-108.
Hong, C. S., Xiao, J., Bush, B., Fitzgerald, E. F. & Hwang, S. A. (1994). Mono
ortho and non-ortho-substituted polychlorinated biphenyls in human
milk from Mohawk and control women: Effects of maternal factors and
118

.......

previous lactation. Archives of Environmental and Contaminated

Toxicology, 27 (3), 431-437.
Hooper, K. & Jianwen, S. (2002). Lessons from the polybrominated diphenyl
ethers (PBDEs): Precautionary principle, primary prevention, and the
value of community-based body burden monitoring using breast milk.

Environmental Health Perspectives, 111, 109-114.
Hooper, L. D. (1989). Chemical risk assessment: A review. Veterinary and

Human Toxicology, 31 (6), 543-552.
Howard, P. H. (1991). Pesticides. Handbook of Environmental Fate and

Exposure Data for OrganiC Chemicals. Chelsea: Lewis Publishers.
Hunter, D. L., Lassiter, T. L., & Padilla, S. (1999). Gestational exposure to
chlorpyrifos: Comparative distribution of trichloropyridinol in the fetus
and dam. Toxicology and Applied Pharmacology, 158, 16-23.
Hytten, F. & Chamberlain, G. (1991). Clinical Physiology in Obstetrics.
Oxford: Blackwell Scientific Publications.
Institute of Medicine (1991). Nutrition during Lactation. Washington D. C.:
National Academy Press.
International Biomonitoring Workshop (2002).
Ito, S. & Koren, G. (1994). A novel index for expressing exposure of infants
to drugs in breast milk. Journal of Clinical Pharmacology, 38, 99-102.
Ivey, M. C., Mann, H. D., Oehler, D. D. (1972). Chlorpyrifos and its oxygen
analogue: Residues in the body tissues of cattle. Journal of Association

Official Analogue of Chemicals, 51 (6),1245-1246.
119

.
Ivey, M. C. & Palmer, J. S. (1979). Chlorpyrifos and 3,5,6-trichloro-2-pyridinol:
Residues in the body tissues of swine treated with chlorpyrifos for hog
louse and itch mite control. Joumal of Ecology and Entomology, 72,
837-838.
Jackson, M.D. & Lewis, R. G. (1981). Insecticide concentrations in air after
application of pest control strips. Bulletin of Contamination and

Toxicology, 27 (1), 122-125.
Jaggy, A. & Oliver, J. E. (1992). Chlorpyrifos toxicosis in two cats. Joumalof

Veterinary Intemal Medicine, 4 (3),135-139.
Joesten, Netterville & Wood (1993). World of Chemistry Essentials. New York:
Saunders College Publishing.
Kaplan, J. G., Kessler, J., Rosenberg, N., Pack, D., & Schaumburg, H. H. (1993).
Sensory neuropathy associated with Dursban (chlorpyrifos) exposure.

Neurology, 43 (11),2193-2196.
Kostyniak, P. J., Stinson, C., Greizerstein, H. B., Vena, J., Buck, G., & Mendola,
P. (1999). Relation of Lake Ontario fish consumption, lifetime lactation,
and parity to breast milk polychlorinated and pesticide concentrations.

Journal of Environmental Reserves, 80 (2 Pt 2), S166-S174.
Kousba, A. A., Poet, T. S., & Timchalk, C. (2003). In vitro rat hepatic and
intestinal metabolism of the organophosphate pesticides chlorpyrifos
and diazinon. Joumal of Toxicological Sciences, 72, 193-200.
Krieger, R. I., Bernard, C. E., dinoff, T. M., Ross, J. H., & Williams, R. L. (2001).
Biomonitoring of persons exposed to insecticides used in residences.
120

......

j,

~
~~
;;

II

Annals of Occupational Hygiene, 45 (suppI1), 143-153.
LaKind, J. S., Berlin, C. M. & Naiman, D. Q. (2001). Infant exposure to chemicals
in breast milk in the United States: What we need to learn from a breast
milk monitoring program. Environmental Health Perspectives, 109 (1),
75-88.
Landrigan, P. J., Claudio, L., Markowitz, S. B., Berkowitz, G. S., Brenner, B. L.,
Romero, H., Wetmur, J. G., Matte, T. D., Gore, A. C., Godbold, J. H., &
Wolff, M. S. (1999). Pesticides and inner-city children: Exposures, risks,
and prevention. Environmental Health Perspectives, 107 (suppl 3),
431-437.
Lassiter, T. L., Barone, S., Moser, V. C., & Padilla, S. (1999). Gestational
exposure to chlorpyrifos: Dose response profiles for cholinesterase and
carboxylesterase activity. Toxicological Sciences, 52 (1),92-100.
Lessenger, J. E. & Reese (1999). Rational use of cholinesterase activity testing
in pesticide pOisoning. Journal ofAmerican Board of Family Practitioners,
12,307-314.
Loewenherz, C., Fenske, R. A., Simcox, N. J., Bellamy, D., & Kalman, D. (1997).
Biological monitoring of organophosphorus pesticide exposure among
children of agricultural workers in central Washington State.

Environmental Health Perspectives, 105, 1344-1353.
Lu, C., Knutson, D. E., Fisker-Anderson, J., & Fenske, R. A. (2001). Biological
monitoring survey of organophosphorus pesticide exposure among pre
school children in the Seattle metropolitan area. Environmental Health
121

II

Perspectives, 109,289-303.
Lu, C., Fenske, R. A., Simcox, N. J., & Kalman, D. (2000). Pesticide exposure of
children in an agricultural community: Evidence of household proximity to
farmland and take home exposure pathways. Environmental Research,
84, 290-302.
Lu, C. & Fenske, R. A. (1999). Dermal transfer of chlorpyrifos residues from
residential surfaces: Comparison of hand press, hand drag, wipe, and
polyurethane foam roller measurements after broadcast and aerosol
pesticide applications. Environmental Health Perspectives, 107, 463-467.
Macintosh, D. L., Needham, L. L., Hammerstrom, K. A., & Ryan, P. B. (1999).
A longitudinal investigation of selected pesticide metabolites in urine.

Joumal of Exposure and Analysis of Environmental Epidemiology, 9,
494-501.
Makris, S., Raffaele, K., Sette, W., & Seed, J. (1998). A retrospective analysis
of twelve developmental neurotoxicity studies submitted to the USEPA
Office of Prevention, Pesticides, and Toxic Substances. Washington, D.C.
Mattson, J. L., Maurissen, J. P., Nolan, R. J., & 8rzak, K. A. (2000). Lack of
differential sensitivity to cholinesterase inhibition in fetuses and neonates
compared to dams treated perinatally with chlorpyrifos. Toxicological

Sciences, 53,438-446.
McDougall, K. W., Wan, H., & Harris, C. R. (1994). The stability of dieldrin, aldrin,
lindane, chlorpyrifos, and prothiofos in stored roof water. Joumalof

Environmental Science and Health, 829 (2), 293-301.
122

f
McKellar, R. L. (1976). Residues of chlorpyrifos , its oxygen analogue, and
3,5,6-trichloro-2-pyridinol in milk and cream from cows fed chlorpyrifos.

Journal ofAgriculture and Food Chemistry, 24 (20), 283-286.
Merrill, R. J. (2001). Regulatory toxicology. In C. D. Klaassen (Ed.), Casarett &

Doull's Toxicology: The Basic Science of Poisons (6th Ed.)
(pp. 1141-1144). New York: McGraw-Hili.
Miles, J. R., Tu, C. M., & Harris, C. R. (1979). Persistence of eight
organophosphorus insecticides in sterile and non-sterile mineral and
organic soils. Bulletin of Environmental and Contaminated Toxicology,
22 (3),312-318.
Miles, P. K. & Zahm, S. H. (2001). Organophosphate pesticide residues in urine
of farmworkers and their children in Fresno County, California. American

Journal of Industrial Medicine, 40, 571-577.
Morgan, M. K., Sheldon, L. S., Croghan, C. W., Jones, P. A., Robertson, G. L.,
Chuang, J. C., & Wilson, N. K. (2004). Exposures of preschool children to
chlorpyrifos and its degradation product 3,5,6-trichloro-2-pyridinol in their
everyday environments. Journal of Exposure and Analysis of

Environmental Epidemiology. online.
Mortensen, S. R, Chanda, S. M., Hooper, M. J., & Padilla, S. Maturational
differences in chlorpyrifos-oxonase activity may contribute to age-related
sensitivity to chlorpyrifos. Journal of Biochemistry and Toxicology, 11,
279-287.
Muto, M. A., Lobelle, F., Bidanset, J. H., & Wurpel, J. (1992). Embryotoxicity and
123

II

.
neurotoxicity in rats associated with prenatal exposure to dursban.
Veterinary and Human Toxicology, 34 (6), 498-501.
National Research Council (1992). Environmental Neurotoxicology. Washington,
D. C.: National Academy Press.
National Research Council. (1993). Pesticides in the diets of infants and children.
Washington, D. C.: National Academy of Press.
Natural Resources Defense Council. Chemicals in mother's milk.
Needham, L. L., Ozkaynak, H., Whyatt, R. M., Barr, D. B., Wang, R. Y., Naeher,
L., Akland, G., Bahadori, T., Bradman, A., Fortmann, R., Liu, S., Morandi,
M., O'Rourke, M. K., Thomas, K., Quackenboss, J., Ryan, P. B., &
Zartarian, V. (2005). Exposure assessment in the National Children's
Study: Introduction. Environmental Health Perspectives, 113 (8),
1076-1082.
Needham, L. L. & Wang, R. Y. (2002). Analytic considerations for measuring
environmental chemicals in breast milk. Environmental Health
Perspectives, 110, A317-A324.
Neville, M. C., Morton, J.,& Umemura, S. (2001). Lactogenesis: The transition
from pregnancy to lactation. Pediatric Clinics of North America, 48 (1),
35-52.
Nolan, R. J., Rick, D. L., Freshour, N. L., & Saunders, J. H. (1984). Chlorpyrifos:
Pharmacokinetics in human volunteers. Toxicology and Applied
Pharmacology, 73, 8-15.
Olson, C. T., Blank, J. A., & Menton, R. G. (1998). Neuromuscular effects of low
124

....

r

II

level exposures to Sarin, pyridostigmine, DEET, and chlorpyrifos. Drug,
Chemistry and Toxicology, 21 (suppI2), 149-169.
O'Rourke, M. K., Lizardi, P. S., Rogan, S. P., Freeman, N. C., Aguirre, A., &
Saint, C. G. (2000). Pesticide exposure and creatinine variation among
young children. Journal of Exposure Analysis and Environmental
Epidemiology, 10,672-681.
Patterson, D. G., Holler, J. S., Belser, W. T., Boozer, E. L, Lapeza, C. R., &
Needham, L. L. (1987). Determination of 2,3,7,8-TCDD in human adipose
on whole-weight and lipid bases. Chemosphere, 16,935-938.
Perea, F. P., Rauh, V., Tsai, W., Kinney, P., Camann, D., Barr, D., Bernert, T.,
Garfinkel, R., Tu, Y., Diaz, D., Dietrich, J., & Whyatt, R. M. (2002).
Effects of transplacental exposure to environmental pollutants on birth
outcomes n a multiethnic population. Environmental Health Perspectives,
111,201-205.
Pesticide Residues Committee (2004). Pesticides residues monitoring report.
Polit, D. F. & Hungler, B. P. (2002). Nursing Research: Principles and Methods.
Lippincott: Philadelphia.
Pons, G., Rey, E., & Matheson, I. (1994). Excretion of psychoactive drugs into
breast milk: Pharmacokinetic principles and recommendations. Clinical
Pharmacokinetics, 27, 270-289.
Quackenboss, J. J., Pellizzari, E. D., Shubat, P., Whitmore, R. W., Adgate, J. L.,
Thomas, K. W., Freeman, N. C., Stroebel, C., Lioy, P. J., et al (2000).
Design strategy for assessing multi-pathway exposure for children: The
125

.
Minnesota children's pesticide exposure study (MNCPES). Journal of

Exposure Analysis and Environmental Epidemiology, 10, 145-158.
Quandt, S. A. (2004). Agricultural and residential pesticides in wipe samples from
farmworker family residences in North Carolina and Virginia.

Environmental Health Perspectives,
Racke, K. D. (1993). Environmental fate of chlorpyrifos. Reviews of

Environmental and Contaminated Toxicology, 13 (1), 1-150.
Robinson, J. C., Pease, W. S., & Albright, D. S. (1994). Pesticides in the home
and community: Health risks and policy alternatives. California Policy
Seminar Report. Center for Occupational and Environmental Health,
School of Public Health. University of California, Berkeley.
Rockett, J. C. (2004). The value of home-based collection of biospecimens in
reproductive epidemiology: Mini-monograph. Environmental Health

Perspectives. Find articles. http://www.looksmart.com.
Rodier, P. M. (1995). Developing brain as a target of toxicity. Environmental

Health Perspectives, 103 (Suppl 6), 73-76.
Rogan, W. J. & Gladen, B. C. (1985). Study of human lactation for effects of
environmental contaminants: The North Carolina breast milk and formula
project and some other ideas. Environmental Health Perspectives, 60,
215-221.
Rogers, J. M. & Kavlock, R. J. (2001). Developmental toxicology. In C. D.
Klaassen (Ed.), Casarett and Doull's Toxicology: The Basic Science of

Posions (6th Ed.) (pp. 351-386).
126

...

f

Rosenstreich, D. L. Eggelston, P., Kattan, M., Baker, D., Slavin, R. G., Gergen,
P., Mitchell, H., McNiff-Mortimer, K., Lynn, H., Ownby, D., & Malveauz, F.
(1997). The role of cockroach allergy and exposure to cockroach allergen
in causing morbidity among inner-city children with asthma. New Eng/and

Jounna/ofAfedicine,336, 1356-1363.
Ruowei, L., Zhao, Z" Mokdad, A" Barker, L, & Grummer-Strawn, L. (2003).
Prevalence of breastfeeding in the United States: The 2001 National
immunization survey. Pediatrics, 111 (5), 1198-1201.
Sanghi, R., Pillai, M. K., Jayalekshmi, T. R., & Nair, A. (2003). Organochlorine
and organophosphorus pesticide residues in breast milk from Bhopal,
Madhya Pradesh, India. Human and Experimental Toxicology, 22, 73-76.
Schecter, A., Papke, 0., Lis, A., Ball, M., Ryan, J. J., Olson, J. R., Li, L., &
Kessler, H. (1996). Decrease in milk and blood dioxin levels over two
years in a mother nursing twins: Estimates of decreased maternal and
increased infant dioxin body burden from nursing. Chemosphere, 32 (3),
543-549.
Schecter, A., Pavuk, M., Papke, 0., Ryan, J. J., Birnbaum, L., & Rosen, R.
(2003). Polybrominated diphenyl ethers (PBDEs) in U. S. mothers'
milk. Environmental Health Perspectives, 111, 1723-1729.
Schecter, A., Ryan, J. J., & Papke, O. (1998). Decrease in levels and body
burden of dioxins, dibenzofurans, PCBs, DOE, and HCB in blood and
milk in a mother nursing twins over a thirty-eight month period.

Chemosphere, 37 (9-12), 1807-1816.
127

.

III

Schmidt, R. R. & Johnson, E. M. (1997). Principles of teratology. In R. D. Hood
(Ed.), Handbook of Developmental Toxicity (pp. 3-12). New York: CRP
Press, Inc.
Selevan, S. G., Kimmel, C. A., & Mendola, P. (2000). Identifying critical windows
of exposure for children's health. Environmental Health Perspectives,
108 (Suppl 3), 451-455.
Sexton, K., Callahan, M. A., & Bryan, E. F. (1995). Estimating exposure and dose
to characterize health risks: The role of human tissue monitoring in
exposure assessment. Environmental Health Perspectives (Suppl 3),
13-30.
Sexton, K., Callahan, M. A., Bryan, E. F., Saint, C. G., & Wood, W. P. (1995).
Informed decisions about protecting and promoting public health:
Rationale for a National Human Exposure Assessment Survey. Journal

of Exposure Analysis and Environmental Epidemiology, 5, 233-256.
Sherman, J. D. (1996). Chlorpyrifos (Dursban) associated birth defects:
Report of four cases. Archives of Environmental Health, 51 (1), 5-8.
Sim, M., Forbes, A., McNeil, J., & Roberts, G. Termite control and other
determinants of high body burdens of cyclodiene insecticides. Archives

of Environmental Health, 53, 114-121.
Simpson, V. R. (1984). Chlorpyrifos and wildlife. The Veterinary Record (Jan.),
101-102.
Solomon, G. M. & Weiss, P. M. (2002). Chemical contaminants in breast milk:
Time trends and regional variability. Environmental Health Perspectives,
128

....JI

,..

II

110, A339-A347.
Srivastava, S. K., Tiwari, P. R., & Srivasta, A. K. (1990). Effects of chlorpyrifos
on the kidney of freshwater catfish. Bulletin of Environmental and Cont

Toxicology, 45, 748-751.
Steenland, K., Dick, R. B., Howell, R. J., Chrislip, D. W., Hines, C. J., & Reed, T.
M. (2000). Neurologic function among termiticide applicators exposed to
chlorpyrifos. Environmental Health Perspectives, 108 (4), 293-300.
Steenland, K. et al (1994). Chronic neurological sequelae to organophosphate
pesticide poisoning. American Joumal of Public Health, 84, 731-736.
Tennessee Agriculture (2004). Tennessee Field Office. http://www.nass.govltn.
Timchalk, C., Nolan, R. J., Mendrala, A. L., Dittenber, A., Brzak, K. A., &
Mattsson, J. L. (2002). A physiologically based pharmacokinetic and
pharmacodynamic model for the organophosphate insecticide chlorpyrifos
in rats and humans. Toxicological Sciences, 66,34-53.
Timchalk, C., Kousba, A. & Poet, T. S. (2004). Development of a physiologically
based pharmacokinetic and pharmacodynamic model to quantitate
biomarkers of exposure to organophosphorus insecticides. EPA Science
Forum.
Tyl, R. W. & Marr, M. C. (1997). Developmental toxicity testing- methodology.
In R. D. Hood (Ed.), Handbook of Developmental Toxicity (pp. 175-226).
U. S. Department of Health and Human Services (1997). Toxicological profile for
chlorpyrifos. Washington D. C.
U. S. Food and Drug Administration (1996). Pesticide program residue
129

.
monitoring. Washington D. C.
U. S. Food and Drug Administration (1995). Pesticide program residue
monitoring for 1994. Washington D. C.
Vale, J. A. (1998). Toxicokinetic and toxicodynamic aspects of
organophosphorus insecticide poisoning. Toxicology Letters,
102-102,49-652.
Vandekar, M. (1980). Minimizing occupational exposure to pesticides:
Cholinesterase determination and organophosphorus poisoning.

Residue Reviews, 75,67-80.
Vandeman, A., Shank, D., Chandran, R., & Vasavada, U. (1992). Lettuce
provides indication of pesticide use and residues. Food Review (Oct-Dec).
Vena, J. E., Buck, G. M., Kostyniak, P., Mendola, P., Fitzgeral, E., Sever, L.,
Freudenheim, J., Greizerstein, H., Zielezny, M., McReynolds, J., & Olson,

J. (1996). The New York State Angler cohort study: Exposure
characterization and reproductive and developmental health. Toxicology

and Industrial Health, 12, 327-334.
Wallinga, D. (1998). Putting children first: Making pesticide levels in food safer
for infants and children. Washington: Natural Resources Defense
Council.
Weiss, B. (2000). Vulnerability of children and the developing brain to neurotoxic
hazards. Environmental Health Perspectives, 108 (Suppl 3), 375-381.
Weiss, B. & Landrigan, P. J. (2000). The developing brain and the environment:
An introduction. Environmental Health Perspectives, 108 (Suppl), 373.
130

....

T"

II

Wessels, D. (2003). Use of biomarkers to indicate exposure of children to
organophosphate pesticides: Implications for a longitudinal study of
child ren's environmental health. Environmental Health Perspectives,

111, 1939-1946.
Wexler, P. (1998). Encyclopedia of Toxicology. San Diego: Academic Press.
Whitmore, R. W., Kelly, J. E., Reading, P. L., Brandt, E., & Harris, T. (1992).
national home and garden pesticide use survey. In K. D. Racke & A. R.
Leslie (Eds.), Pesticides in Urban Environments: Fate and Significance
(pp. 18-36). Washington, D. C.: American Chemical Society.
Whitmore, R. W., Immerman, F. W., Camann, D. E., Bond, A. E., Lewis, R. G.,

& Schaum, J. L. (1994). Non-occupational exposures to pesticides for
residents of two U. S. cities. Archives of Environmental Contaminated
Toxicology, 26,47-59.
Whitney, K. D., Seidler, F. J., & Siotin, T. A. (1995). Developmental neurotoxicity
of chlorpyrifos: Cellular mechanisms. Toxicology and Applied
Pharmacology, 134, 53-62.
WHO. (1996). Levels of PCBs, PCDDs and PCDFs in human milk: Second round
of WHO coordinated study.
Whaytt, R. M., Rauh, V., Barr, D. B., Camann, D. E., Andrews, H. F., Garfinkel,
R., Hoepner, L. A., Diaz, D., Dietrich, J., Reyes, A., Tang, D., Kinney,
P. L., & Perea, F. P. (2004). Prenatal insecticide exposures and birth
weight and length among an urban minority cohort. Environmental
Health Perspectives, 112 (10), 1125-1132.

131

.
Whyatt, R. M., Camann, D. E., Kinney, P. L, Reyes, A., Ramirez, J., Dietrich, J.,
Diaz, D., Holmes, D. & Perera, F. P. (2002). Residential pesticide use
during pregnancy among a cohort of urban minority women.
Environmental Health Perspectives, 110 (5),
Whyatt, R. M. & Barr, D. B. (2001). Measurement of organophosphate
metabolites in postpartum meconium as a potential biomarker of prenatal
exposure: A validation study. Environmental Health Perspectives, 109 (4),
417-419.
Whyatt, R. M., Camann, D. E., Kinney, P. L, Reyes, A., Ramirez, J., Dietrich, J.,
Diaz, D., Holmes, D., & Perera, F. P. (2002). Residential pesticide use
during pregnancy among a cohort of urban minority women.
Environmental Health Perspectives, 110, 507-514.
Wickizer, T. M., Brilliant, L B., Copeland, R., & Tilden, R. (1981). Polychlorinated
biphenyl contamination of nursing mothers' milk in Michigan. American
Journal of Public Health, 71 (2),132-137.
Wigle, D. T. (2003). Child Health and the Environment. New York: Oxford Press.
Wilson, J. T. (1981). Pharmacokinetics of drug excretion. In J. T. Wilson (Ed.),
Drugs in breast milk. Australia: ADIS Press.
Wright, C. G., Leidy, R. B., & Dupree, H. E. (1994). Chlorpyrifos in the air and soil
of houses eight years after its application of termite control. Bulletin of
Environmental and Contaminated Toxicology, 52 (1), 131-134.
Zwiener, R. J. & Ginsburg, C. M. (1988). Organophosphate and carbamate
poisoning in infants and children. Pediatrics, 81 (1), 121-126.
132

....

.
BIBLIOGRAPHY
Abraham, K., Papke, 0, Gross, A., Kordonouri, 0., Wiegand, S., Wahn, U.,

& Helge, H. (1998). Time course of PCDD/PCDF/PCB concentrations
in breast-feeding mothers and their infants. Chemosphere, 37 (9-12),
1731-1741.
Anderson, H. A. & Wolff, M. S. (2000). Environmental chemicals in human
milk. Journal of Exposure Analysis and Environmental Epidimeology,
10,755-760.
Aprea, C., Strambi, M., Novelli, M. T., Lunghini, I., & Bozzi, N. (2000). Biologic
monitoring of exposure to organophosphorus pesticides in 195
Italian children. Environmental Health Perspectives, 108,521-525.
Arbuckle, T. E. & Sever, L. E. (1998). Pesticide exposures and fetal death:
A review of the epidemiologic literature. Critical Reviews in Toxicology,
28 (3), 229-270.
Aylward, L. L., Hays, S. M., LaKind, J. S., & Ryan, J. J. (2003). Rapid
communication: Partitioning of persistent lipophilic compounds,
including dioxins, between human milk lipid and blood lipid: An
initial assessment. Journal of Toxicology and Environmental Health,
66 (1), 1-5.
Banta-Wright, S. A. (1997). Minimizing infant exposure to and risks from
medications while breastfeeding. Journal of Perinatal and Neonatal

Nursing, 11 (2), 71-84.

134

Jill

~

II

Buck, G. M., Vena, J. E., Greizerstein, H. B., Weiner, J. M., McGuinness, B.,
Mendola, P., Kostyniak, P. J., Swanson, M., Bloom, M. S., & Olson, J. R.
(2002). PCB congeners and pesticides and female fecundity, New York
State Angler prospective pregnancy study. Environmental Toxicology and

Pharmacology, 12,83-92.
Carr, R. L., Chambers, H. W., Guarisco, J. A., Richardson, J. R, Tang, J., &
Chambers, J. E. (2001). Effects of repeated oral postnatal exposure to
chlorpyrifos on open-field behavior in juvenile rats. Toxicological

Sciences, 59, 260-267.
Crinnion, W. J. (2000). Environmental Medicine, part 4: Pesticides
biologically persistent and ubiquitous toxins. Alternative Medicine

Review, 5 (5), 432-447.
Curl, C. L. (2002). Evaluation of take-home organophosphorus pesticide
exposure among agricultural workers and their children. Environmental

Health Perspectives, 110 (A787-A792).
Davis, D. L. & Ahmed, A. K. (1998). Exposures from indoor spraying of
chlorpyrifos pose greater health risks to children than currently estimated.

Environmental Health Perspectives, 106, 299-301.
DeKoning, E. P. & Karmaus. W. (2000). PCB exposure in utero and via
breast milk. A review. Journal of Exposure Analysis and

Environmental Epidemiology, 10 (3), 285-293.
Eskenazi, B., Bradman, A., & Castorina, R. (1999). Exposures of children to
organophosphate pesticides and their potential adverse health effects.
135

III

Environmental Health Perspectives, 107 (5uppI3), 409-419.
Faustman, E. M., Silbernagel, 5. M., Fenske, R. A., Burbacher, T. M., & Ponce,
R. A. (2000). Mechanisms underlying children's susceptibility to
environmental toxicants. Environmental Health Perspectives, 108
(5uppI1), 13-21.
Grady, P. A., Harden, J. T., Moritz, P., & Amende, L. M. (1997). Incorporating
environmental sciences and nursing research: An NINR initiative. Nursing

Outlook, 45, 73-75.
Griffin, P., Mason, H., Heywood, K., & Cocker, J. (1999). Oral and dermal
absorption of chlorpyrifos: A human volunteer study. Occupational and

Environmental Medicine, 56 (1),10-30.
Hamosh, M. (2001). Bioactive factors in human milk. Pediatric Clinics of North

America, 48 (1), 69-86.
Hooper, K. & McDonald, T. A. (2000). The PBDEs: An emerging environmental
challenge and another reason for breast-milk monitoring programs.

Environmental Heatlh Perspectives, 108 (5),387-392.
Landrigan, P. J., Claudio, L., Markowitz, 5. B., Berkowitz, G. 5., Brenner, B. L.,
Romero, H., Wetmer, J. G., Matte, T. D., Gore, A. C., Godbold, J. H., &
Wolff, M. 5. (1999). Pesticides and inner-city children: Exposures, risks,
and prevention. Environmental Health Perspectives, 107 (53), 1-14.
Lorber, M. & Phillips, L. (2002). Infant exposure to dioxin-like compounds in
breast milk. Environmental Health Perspectives, 110, A325-A332.

136

If

II

Moya, J., Bearer, C. F., & Etzel, R. A. (2004). Children's behavior and physiology
and how it affects exposure to environmental contaminants. Pediatrics,
113 (4),996-1006.
Needham, L. L. & Sexton, K. (2000). Asessing children's exposure to hazardous
environmental chemicals: An overview of selected research challenges
and complexities. Journal of Exposure Analysis and Environmental

Epidemiology, 10, 611-629.
Nurminen, T. (2001). The epidemiologic study of birth defects and pesticides.

Epidemiology, 12 (2), 1-2.
O'Hara, M. A. (2000). Organochlorides in breastmilk: Health impact. Academy of

Breastfeeding Medicine, 6 (4), 27-32.
Oliver, G. R., Bolles, H. G., & Shurdut, B. A. (2000). Chlorpyrifos: Probabilistic
assessment of exposure and risk. Neurotoxicology, 21 (1-2),203-208.
Pronczuk, J., Akre, J., Moy, G., & Vallenas, C. (2002). Global perspectives in
breast milk contamination: Infectious and toxic hazards. Environmental

Health Perspectives, 110, A349-A351.
Recio, R. (2001). Organophosphorus pesticide exposure increases the
frequency of sperm sex null aneuploidy. Environmental Health

Perspecuves, 109, 1237-1240.
Rice, D. & Barone, S. (2000). Critical periods of vulnerability for the developing
nervous system: Evidence from humans and animal models.

Environmental Health Perspectives, 108 (SuppI3), 511-533.
137

.,
Schecter, A., Kassis, I., & Papke, O. (1998). Partitioning of dioxins,
dibenzofurans, and coplanar PCBs in blood, milk, adipose tissue,
placenta and cord blood from five American women. Chemosphere, 37
(9-12), 1817-1823.
Sim, M. (1998). Termite control and other determinants of high body burdens
of cyclodiene insecticides. Archives of Environmental Health (Mar-Apr),
1-16.
Simcox, N. J., Fenske, R. A., Wolz, S. A., Lee, I., & Kalman, D. A. (1995).
Pesticides in household dust and soil: Exposure pathways for children
of agricultural families. Environmental Health Perspectives, 103 (12),
1126-1134.
Slusser, W., & Powers, N. G. (1997). Breastfeeding update1: Immunology,
nutrition, and advocacy. Pediatrics in Review, 18 (4), 111-119.
WaIIinga, D. & Greer, L. (2000). Poisons on pets: Health hazards from flea and
tick products. Natural Resources Defense Council. Washington D. C.
Zartarian, V. G., Ozkaynak, H., Burke, J. M., Zufall, M. J., Rigas, M. L., & Furtaw,
E. J. (2000). A modeling framework for estimating children's residential
exposure and dose to chlorpyrifos via dermal residue contact and
nondietary ingestion. Environmental Health Perspectives, 108 (6),
505-514.

138

...

"

,

VITA
Karyn Ann Casey was born in Lubbock, Texas on March 06, 1962. She
was raised in Lubbock and graduated from Monterey High School in 1980. She
attended Texas Tech University Health Sciences Center College of Nursing in
Lubbock, Texas and received a Bachelor of Science Degree. She moved to
Dallas, Texas and worked at Children's Medical Center while obtaining her
Master's Degree in Nursing from Texas Woman's University in Dallas, Texas.
Karyn also received certification from the National Pediatric Association as a
Certified Pediatric Nurse Practitioner. In 1999 she married Mike Casey, an
orthopedic surgeon who completed his residency at University of Texas at
Southwestern. They moved to Knoxville, Tennessee where Karyn completed
requirements for the doctorate in nursing at the University of Tennessee College
of Nursing.

139

